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1. Introduction 
1.1 NADPH oxidase 
NADPH oxidases (nicotinamide adenine dinucleotide phosphate oxidase) are membrane 
bound enzyme complexes that have the primary function to generate superoxide anions. 
The enzyme was originally described in phagocytic cells of the immune system, 
particularly in neutrophils. This NADPH oxidase type is the best explored and consists of 
five subunits: gp91phox (glycoprotein-91kDa-phagocytic-oxidase) (newly termed 
NOX2), p22phox, p47phox (newly termed NOXO2), p67phox (newly termed NOXA2), 
p40phox and the GTPase Rac1. The gp91phox and p22phox subunits are membrane 
bound. Recently, different types of NADPH oxidases were identified in non-phagocytic 
cells, among them are endothelial cells, smooth muscle cells, fibroblasts and epithelial 
cells. In these types of NADPH oxidases, the NOX2 subunit is replaced by several 
homolog subunits named: NOX1, NOX3, NOX4 and NOX5 with molecular weights in 
the range of 63-68kDa [1]. These homologs share considerable similarities with NOX2 in 
amino acid sequence, conformation and structural domains. Other homologs with lower 
degree of similarity to NOX2 represent DUOX1 and DUOX2. DUOXs are proteins of 
about 160kDa containing additional transmembrane and calcium binding domains at the 
N-terminus [2], [3]. Also, homologs of p47phox (NOXO2) and p67phox (NOXA2) 
named NOXO1 and NOXA1 have been identified. These subunits are critical for a 
functional and active NOX1, NOX2 and NOX3 containing NADPH oxidases [4] [5] 
(Figure 1). 
 
1.1.1 Functions of NADPH oxidases and NOX subunits  
The primary function of NADPH oxidase is the generation of superoxide anions (O2.-). 
O2.- formation is based on reduction of molecular oxygen (O2) by one electron. There are 
specific domains in the NOX subunits that bind the cofactors NADP+ and FAD and a 
hem iron that mediates the electron transfer to O2 as terminal acceptor. The electron flow 
is according to an increasing redox potential of individual components, i.e. from 
NAD(P)+ to FAD to hem iron to O2 [6], [5]. Whereas the C-terminal part of NOX is 
important for binding of NAD(P)+, FAD and further NADPH oxidase subunits, the N- 
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Figure 1: Activation and organization of NADPH oxidase subtypes  
Despite of similarities in structure and enzymatic function, individual NOXs differ in 
their mechanism of activation. NOX1 activity requires p22phox, NOXO1 (or possibly 
p47phox in some cases) and NOXA1, and the small GTPase Rac. NOX2 requires 
p22phox, p47phox, p67phox, and Rac. p47phox phosphorylation is required for NOX2 
activation. Although not absolutely required, p40phox also associates with this complex 
and may contribute to activation. NOX3 requires p22phox and NOXO1. The requirement 
for NOXA1 may be species dependent, and the requirement of Rac is still debated. 
NOX4 requires p22phox, but in reconstitute systems it is constitutively active without the 
requirement for other subunits. However, in native NOX4-expressing cells, activation, 
possibly including Rac, has been described. NOX5, DUOX1, and DUOX2 are activated 
by Ca2+ and do not appear to require other subunits. [5] 
 
terminal part contains several histidine residues that are essential for the covalent binding 
of hem. Amino acids in the N-terminal part of the NOX protein form up to six 
hydrophobic alpha helices that have been suggested to pass cell membrane. Interestingly, 
the truncated C-terminal half of NOX displays a diaphorase activity [7], [8], i.e. the 
ability to reduce chromogenic electron acceptors, whereas the N-terminal half has proton 
conductance properties. The proton conductance is likely based on protonation and 
deprotonation of the flexible imidazole ring of histidines localized in the transmembrane 
domains of NOX. It may play a role in regulation of the intracellular pH [9], [10], [11].  
Introduction 
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Electron flow and superoxide generation are conditioned by the interaction of NOX with 
other NADPH oxidase subunits enabling binding of NADPH, FAD and the activation of 
NOX [4] [5]. The function and structure of individual NADPH oxidase subunits are 
described below (chapter 1.1.2) and schematically depicted (Figure 1 and 2).          
 
1.1.2 Subunits of NADPH oxidases 
1.1.2.1 NOX1 and NOX4  
NOX1  
NOX1 was the first described homolog of NOX2. NOX1 shares 60% amino acid 
sequence identity with NOX2 [5]. One alternative splice variant (NOX1v) lacking exon 
11 has been identified. The exon 11 encodes amino acids predicted to participate in the 
binding of NADPH thereby the lack of this region diminishes the ability of NOX1v to 
generate ROS [12]. p22phox, NOXO1 (or p47phox) and NOXA1 (or p67phox) seem to 
be essential for the function of NADPH oxidase containing NOX1, i.e. NADPH oxidase 
1 [4] [5] [13].    
The predicted sizes of NOX1 and NOX1v are 65kDa and 59kDa respectively, however 
the commonly observed NOX1 bands in SDS-PAGE have 50-65 kDa [14], [15], [16], 
[17], [18], [19], [20]. Of note is that immuno-detection of NOX proteins is not well 
established and different antibodies differ in their immunoreactivity. Thus, also the 
subcellular localization of endogenous NOX1 is controversially described. Most of the 
studies with recombinant NOX1 protein show localization in the cell membranes, 
particularly in the plasma membrane [21], [22], [23],  [24], [25]. Using 
immunofluorescence microscopy, also endogenous NOX1 protein displayed surface 
distribution along the cellular margins [26] where it was colocalized with caveolin-1 [18]. 
Also, subcellular fractionation detected NOX1 in fractions containing membranes [16], 
[27]. One recent study demonstrated colocalization of recombinant NOX1 with F-actin 
and cortactin in invadopodia of cancer cells [28]. On the other hand, other studies showed 
endogenous or overexpressed NOX1 protein also in the nuclei, cytosol [29], at 
endoplasmic reticulum (ER) [25] and even mitochondria [30]. 
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NOX1 was found in many different cell- and tissue-types. Nevertheless, the highest 
expression level of NOX1 was detected in colon epithelium and in a cell line derived 
from colorectal carcinoma (CaCo2) [1], [31], [32], [33]. The NADPH oxidase 1 in 
intestinal epithelial cells may be an important component of mucosal host defense. In 
accordance with the high abundance of NOX1 in different cancer cell lines, it has been 
shown that overexpression of NOX1 in NIH3T3 cells led to increased mitotic rate, cell 
transformation and tumorigenicity [34], [32]. In particular, NOX1 derived ROS are 
involved in Ras dependent malignant transformation [35], [36]. The mechanism of 
transformation may involve NOX1-derived ROS triggering mutagenesis in oncogenes or 
tumor suppressor genes, and an action of NOX1-derived ROS as intracellular mediators 
in the regulation of proliferation [37], [35]. The relevant ROS targets related to growth 
and transformation may include p42/p44 mitogen activated protein kinase (MAPK) [38], 
[39], p38 MAPK [40], [41], p70S6kinase [42], signal transducers and activators of 
transcription (STAT) [43], vascular endothelial growth factor (VEGF) [44], [36], Akt1 
(alias protein kinase B) [45] protein tyrosine phosphatase-1B [46], nuclear factor kappa-
light-chain-enhancer of activated B cells (NF-κB) [47],[48], [49] and activator protein-1 
(AP-1) [50], [34]. Also, this aspect is important in different cardiovascular diseases.  
On the other hand, many signaling mediators have been shown to induce NOX1. NOX1 
mediated ROS generation can be triggered by platelet-derived growth factor (PDGF), 
epidermal growth factor (EGF), prostaglandin F2α (PGF2α) [51], [52], [53], [54], and by 
angiotensin II (Ang II) [55], [56]. The molecular mechanism of NOX1 activation by 
these factors includes signaling cascades leading to increased NOX1-mRNA expression 
or activation of NADPH oxidase subunits. Components of signaling cascades leading to 
an elevation of NOX1 expression may include different kinases that converge 
downstream in the activation of transcription factors such as GATA6 or activating 
transcription factor 1 (ATF-1) which are binding directly to the promoter regions of the 
NOX1 gene [52], [37]. Particularly in regard to malignant transformation, Ras dependent 
activation of NOX1 through the MEK/ERK pathway and GATA6 factor has been 
demonstrated [57].  
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NOX4 
NOX4 is a 67kDa protein sharing 39% amino acid identity with NOX2 [58], [5]. Five 
splice variants of NOX4 resulting in different truncated forms have been identified at the 
mRNA level [59]. However, it is not clear whether they are also endogenously expressed 
at the protein level and thus also their functional role is not clear. Similarly to NOX1, the 
detection of NOX4 by antibodies is not well established. In many studies, in addition to 
the 67kDa protein band likely representing NOX4 full length, a putative band at 75-
80kDa has been detected [60], [18], [61], [62], [63], [64]. Whether this band represents, 
for example, a posttranslational modification of NOX4 or other NOX4 splice variants is 
not known.  
NOX4 is predominantly localized at the ER [21], [25] and in the nuclei [65], [18]. In 
addition, a colocalization of NOX4 with cytoskeleton and focal adhesions has been 
demonstrated [18], [64], [66]. p22phox appears to be the only subunit that is essential for 
the function of the NOX4 containing NADPH oxidase 4. Thus, the enzymatic activity of 
NADPH oxidase 4 mainly depends on the expression level of NOX4 and p22phox and 
probably does not need any further activation [67]. The type of ROS generated by NOX4 
has been determined in some studies as H2O2, unlike NOX1 that is primarily producing 
O2.- [21]. NOX4 is functionally linked to senescence [58], proinflammatory responses, 
oxygen sensing [68], migration, differentiation [66], [69], proliferation [70], [71], [62] 
and apoptosis [72], [73]. This is in agreement with the association of NOX4 with 
cytoskeleton and focal adhesions, since both of these cellular compartments are involved 
in these processes. Mechanisms of NOX4 acting on cytoskeletal and focal adhesions may 
involve different structural changes of these proteins, e.g. phosphorylation, and/or direct 
regulation of relevant targets transcription by ROS [74], [66], [75], [62]. For example, 
ROS has been shown to induce the activity of p125FAK (non receptor protein tyrosine 
kinase) that in turn phosphorylates cytoskeleton associated proteins paxillin and p130cas 
[76]. Another study showed, that NOX4 in complex with Poldi2 protein ((DNA-directed), 
delta interacting protein 2) exerts an effect on focal adhesions turnover, stress fiber 
formation and VSCM migration by activation of RhoA protein (Rho GTPase family 
proteins regulate actin dynamic) [64].    
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1.1.2.2 p22phox, NOXO, NOXA, p40phox, Rac    
p22phox 
p22phox is a 22kDa basic, transmembrane protein that plays an important role during 
NOXs protein synthesis in the ER [77], [78] and it is essential for the function of 
NADPH oxidase since it mediates anchoring NOXs in the membrane and supports the 
interaction of NOX with the NOXO subunit [79],[80], [81], [82]. p22phox consists of 
two transmembrane domains at the N-terminal part and a proline rich region at the C-
terminal part [79]. The proline rich region is critical for binding to the NOXO subunit . 
(Figure2)  
NOXO 
The NOX organizer (NOXO) is a 47kDa basic protein with a regulatory function of 
NADPH oxidase activity. It may translocate to the membrane upon phosphorylation [83] 
where it interacts with p22phox by a Scr homology 3 (SH3) domain [84], [80] and with 
the phospholipid membrane by a phox homology domain (PX) [23]. NOXO2 (originally 
named p47phox) and NOXO1, two known homologs of NOXO, appear to have similar 
functions in the activation of NOX2 and NOX1, respectively [33], [5]. However, they 
differ in specific properties, such as the ability of binding specific components of the 
membrane and the ability of autoregulation - NOXO2 contains autoinhibitory domains 
that is deactivated upon phosphorylation, whereas NOXO1 seems to be constitutively 
active [5]. A proline rich region of NOXO enables its interaction with NOXA. (Figure 2) 
NOXA 
The NOX activator (NOXA) contains several TPR (tetratricopeptide repeat) motifs at the 
N-terminus within the activation domain, a phox-Bem1 region in the central part and a 
SH3-homolog sequence at the C-terminus [5]. NOXA2 with a size of 67kDa (originally 
named p67phox) and its homolog NOXA1 with a size of 51kDa bind to NOX2 and 
NOX1, and mediate NOX interaction with the NOXO subunit. Similarly to NOXOs, also 
NOXA2 and NOXA1 differ in their structural properties - they only share 30% identity in 
the amino acid sequence [33]. Both NOXA2 and NOXA1 (similarly as NOXO2 and 
NOXO1) can substitute for each other, however the substitution has significant impact on 
NOX2 and NOX1 functions [85]. The TPR domain is important for Rac binding [86], 
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[87], the phox-Bem1 region for p40phox binding [85], the SH3 domain for NOXO 
interaction [88], [89], [80], and the activation domain is critical for the activation of 
NOXs [90]. (Figure 2) 
p40phox 
p40phox (40kDa) is a protein also containing PX region, a SH3 domain and in addition 
an octicosa peptide repeat. The PX domain interacts with components of the 
phospholipide membrane, the SH3 domain with NOXO and the octicosa peptide repeat 
with NOXA [91], [5]. p40phox can also be phosphorylated upon stimulation, such as 
oxidative stress, by PKCδ [92]. (Figure2) 
Rac GTPase 
Rac is a small (21kDa) G protein from the Rho family of GTPases. The N-terminal part 
of the protein binds GTP or GDP and displays a GTPase activity. The exchange of GDP 
for GTP leads to the activation of Rac and is prevented by the Rho GDP dissociation 
inhibitor (RhoGDI) that interacts with the C-terminal hydrophobic region of Rac in resting 
cells [93]. The function of Rac in the NADPH oxidase complex is likely to activate 
NOXA which occurs when Rac is released from RhoGDI and GTP is bound to Rac [94], 
[95], [24], [54]. (Figure 2) 
 
1.1.2.3 Assembling and activation of NADPH oxidase subunits 
The importance of the individual subunits, sequence and stimuli of activation of different 
subtypes of NADPH oxidase are partially explored. Most of the studies have been 
performed on the phagocytic NADPH oxidase (containing NOX2) which is the best 
described functional model of this enzyme (Figure 3). The model suggests that NOX2 
and p22phox are constitutively expressed in the plasma membrane [13]. Upon activation, 
NOXO2 is phosphorylated and binds to p22phox [84], [83], which is a docking place for 
NOXO2 and NOXA2. Interestingly, NOXO1 unlike NOXO2 activation appears to be 
independent on phosphorylation. NOXA translocation to the membrane and its 
consequent interaction with NOXO seems to be dependent on the stimulation of NOXA 
by the Rac subunit which is likely changing the conformation of the NOXA activation 
domain [94], [95].  
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Figure 2: Proposed organization of NADPH oxidase subunits 
NOX1, NOX2, NOX3, NOX4 and NOX5 contain six conserved transmembrane domains 
at the N-terminal part. The transmembrane domains III and V contain two histidine 
residues binding two hemes. The cytoplasmic C-terminal part of NOXs contains 
conserved domains binding FAD and NADPH. NOXs interact with the p22phox subunit 
a transmembrane protein linking further NADPH oxidase subunits to NOXs. NOXO 
(p47phox), NOXA (p67phox), p40phox are NADPH oxidase subunits containing specific 
domains critical for mutual interaction, association with the cell membranes and are 
important for NADPH oxidase function. Rac GTPases are involved in the regulation of 
NADPH oxidase complexes but they do not belong to NADPH oxidase subunits in the 
strict sense. Rac plays probably a role in the activation of NOXA. The importance of the 
individual subunits for the activation of different NOX subtypes is not fully explored (see 
Figure 1). Here depicted model is suggested to be relevant mainly for NOX1 and NOX2. 
All NOXs are though to be single electron transporters, passing electrons from NADPH 
to FAD to the first and to the second heme iron and finally to molecular oxygen.                         
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When NOXA and NOXO are docked in the membrane, p40phox can interact with NOXA  
subunit. The role of p40phox in the NADPH oxidase complex is probably that it supports 
to anchor other subunits in the cell membrane [13], [96]. Proper assembling of all 
subunits consequently forms a specific tertiary structure of NADPH oxidase enabling 
effective ROS generation. An involvement of individual NADPH oxidase subtypes in 
different cellular signaling events is achieved not only through different patterns of their 
activation by cytosolic subunits but also by their cell and tissue type specific expression 
and particular subcellular localization.         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Activation of NADPH oxidase 2 
Activation of the gp91phox (NOX2) system occurs by at least three signaling triggers 
that result in the assembly of the cytosolic regulatory proteins (p40phox, p47phox and 
p67phox) with flavocytochrome b558 (comprised of the membrane-associated catalytic 
subunit gp91phox plus p22phox). These triggers involve protein kinases, lipid-
metabolizing enzymes and nucleotide-exchange proteins that activate the GTPase Rac. 
Protein kinases, including protein kinase C and Akt, catalyse many phosphorylations of 
the autoinhibitory region (AIR) of p47phox, releasing its binding to the bis-SRC-
homology 3 (SH3) domain, allowing p47phox to bind to p22phox. This also relieves the 
inhibition of the Phox homology (PX) domain of p47phox, allowing binding to lipids. 
Because p47phox also binds to p67phox, it has been described as an organizer protein. 
Phosphatidylinositol 3-kinase (PI3K) and phospholipase D produce 3-phosphorylated 
phosphatidylintositols (PtdInsP) and phosphatidic acid, respectively, providing lipids to 
which the p47phox and p40phox PX domains bind. Rac is post-translationally modified 
with a carboxy-terminal hydrophobic geranyl-geranyl group. In Rac-GDP, this group is 
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masked by the inhibitory protein RhoGDP-dissociation inhibitor (RhoGDI), maintaining 
Rac in the cytosol. Activation of exchange factor(s) triggers GTP binding, resulting in 
conformational changes in Rac that promote dissociation from RhoGDI and membrane 
association through the geranyl-geranyl lipid. The conformational change also promotes 
Rac binding to the tetratricopeptide (TPR) region of p67phox, helping to assemble the 
active complex. [4]  
 
1.2 Reactive oxygen species 
1.2.1 Types of ROS, oxidative stress and antioxidants 
Reactive oxygen species (ROS) include a number of chemically reactive molecules 
derived from oxygen. Some of them such as superoxide anion are free radicals, i.e. 
molecules with unpaired electrons in the atom valence shell, whereas others do not 
belong to the group of free radicals but they only exhibit high reactivity due to their 
strong oxidative properties. The major types of ROS in mammalian cells are: superoxide 
anion (O2.-) a product of NADPH oxidases; hydrogen peroxide (H2O2) that can be 
generated either by conversion of O2.- or directly by some enzymes; peroxy radicals 
(ROO.), generated by reaction of lipid radicals with O2.-; organic hydroperoxide (ROOH) 
a product of lipid peroxidation; hydroxyl radical HO. a product of the Fenton reaction - 
the reaction of metals with H2O2; hypochlorous acid (HOCl) generated by 
myeloperoxidase [97], [98], [99].  
ROS can readily react with many types of biomolecules leading to alterations of their 
structure or leading to the initiation of a chain reaction forming free radicals. In order to 
stop this chain reaction, a newly formed radical must either react with another free 
radical, eliminating the unpaired electrons or must react with a free radical scavenger. An 
imbalance between the production of ROS and the ability of the biological system to 
detoxify the reactive intermediates or to repair the resulting damage causes so called 
oxidative stress. Agents protecting cell from oxidative stress, i.e. antioxidants are either 
small molecules often with reducing effect (glutathione, ascorbic acid, polyphenols) or 
enzymes (thioredoxin, glutaredoxin, superoxide dismutase, catalase) [100], [99], [101]. 
The role of ROS in the organism is however much more complex. ROS are also 
generated as a natural product of the oxygen metabolism and they play an important role 
in the defense of organisms against pathogens and in cellular signaling [102].  
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1.2.2 Cellular sources of ROS 
ROS may be generated by enzymatic reactions as a primary product or as side-product. 
ROS are produced as side-product within the mitochondrial electron transport chain 
[103], of xantin oxidase [104], of cytochrom P-450 [105], of lipooxygenase [106] and 
other enzymes in the ER [107] and of peroxisomes [108]. On the other hand, 
myeloperoxidase and NADPH oxidases are enzymes that have the primary function to 
produce ROS [100]. Both enzymes were originally discovered in the phagocytic cells of 
the immune system, paricularly in neutrophils. Later, also other non-phagocytic NADPH 
oxidase types have been described. These types of NADPH oxidases generate ROS that 
are important rather in cellular signaling than in defence against pathogens.  
 
1.2.3 Mechanisms of ROS impact on cell signaling    
An essential role of ROS in cellular signaling has been demonstrated in many studies. 
The concept of ROS signaling is based on oxidative modifications of proteins. This may 
work by at least two mechanisms. Either by alteration of the redox state of the glutathione 
(Gth) and the thioredoxin (Trx) systems that are the two most important cellular “redox 
buffers” or by direct oxidation of target proteins [102], [101]. The “reducing” 
environment of cells is accomplished by the “redox buffering” capacity of the Gth and 
Trx systems. Trx and Gth may regulate cell signaling by donating or accepting electrons 
[102]. An optimal ratio of reduced and oxidized Gth as electron donor-acceptor is critical 
for an effective enzymatic regulated protein folding [107], [109] that also significantly 
impacts cell signaling. Furthermore, both Gth and Trx were described to physically and 
functionally interact with different transcription factors. The ability of Gth and Trx to 
interact with various signaling molecules directly correlates with the ratio of their 
reduced and oxidized forms in the cell. For example, STAT3 [110], c-Jun [111], and IκB 
kinase (IKK-β) [112] are targets of glutathionylation and apoptosis signal-regulating 
kinase (ASK1) [113], redox factor 1 Ref-1 [114], [115] are bound by Trx [102]. Trx, in 
dependency on its redox state, also regulates the function of HIF-1α [116], NF-κB [117] 
and AP-1 [118], [119].  
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The mechanism of direct oxidation of signaling proteins by ROS may include [102], [97]: 
1. oxidation of cysteine residues (e.g. p53 transcription factor oxidation [120], [121], 
[122], HIF-1α can be destabilized by oxidation of particular cysteine residues [123]), 2. 
formation of intra- or inter-molecular disulfide linkages (e.g. ASK1 homodimerization 
[124]), 3. H2O2-dependent formation of di-tyrosine (e.g. ROS participate in di-tyrosine 
formation of the amyloid β peptide in Alzheimer’s diseases [125]), 4. oxidation of 
proteins by metal catalyzed reactions. For example, many enzymes contain metal ions in 
their active sites. The metal ion can consequently catalyze oxidation of these proteins by 
Fenton reaction, i.e. reaction of hydrogen peroxide with metal leading to generation of 
reactive hydroxyl radical [102], [126].     
 
1.2.4 ROS, oxygen sensing and hypoxia inducible factor 1  
1.2.4.1 HIF-1 is a target of oxygen sensors 
Celluar oxygen sensing mechanisms exist that function in order to maintain cellular 
oxygenation under conditons of decreased partial oxygen pressure (pO2) levels (i.e. 
hypoxia). At the level of gene regulation, oxygen sensor dependent signaling is mediated 
by the hypoxia inducible factor 1 (HIF-1) [127], [128]. HIF-1 was detected as the first 
transcription factor which was specifically induced by hypoxia [129], [130], [131], [132]. 
It was discovered during investigations of the molecular mechanism of erythropoietin 
induction, which induces erythropoiesis, and thus improves the oxygen-binding capacity 
of blood. In subsequent studies, it emerged that HIF-1 directly affects an increasing 
number of identified target genes which are involved in hypoxic adaptation processes and 
are activated by a common hypoxia responsive DNA binding element [133], [134], [135]. 
The HIF-1 complex is a heterodimer consisting of two structurally similar subunits: HIF-
1α and HIF-1β (HIF-1β is ARNT, aryl hydro-carbon nuclear translocator) (Figure 4). 
Further HIF-1α homologs, termed HIF-2α [136] and HIF-3α [137], and homologs of 
ARNT, termed ARNT2 [138] and ARNT3 [139] have been identified and are all encoded 
by different genes. The α-subunit of HIF is the regulatory subunit, while the β-subunit is 
constitutively expressed. Heterodimerization of the α- and β-subunit is essential for 
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activation of HIF-dependent target genes. The HIF-1α is the relevant regulatory subunit 
for responses induced by hypoxia [140].  
The N-terminal domain of HIF-1α is important for dimerization with HIF-1β and DNA 
binding. This domain contains a basic-helix-loop-helix and two PAS (Per, ARNT, SIM) 
motifs sharing homology with other transcription factors of this group. The C-terminal 
domain is the regulatory domain which contains an oxygen-dependent degradation 
domain (ODDD) and itself can be divided into a C-terminal transactivation domain (C-
TAD) and N-terminal transactivation domain (N-TAD) [127].  
 
1.2.4.2 Regulation of HIF by the oxygen sensors prolyl 4-hydroxylase and 
asparaginyl hydroxylase  
Specific oxygen dependent enzymes exist that sense the induction of HIF-1. The 
regulation of HIF-1 activation occurs mainly at the level of protein stabilization via HIF 
prolyl 4-hydroxylases (PHD) which hydroxylate prolines at position 402 and 564 [141], 
[142]. If the proline-residues are hydroxylated as observed under normoxic conditions, 
von Hippel Lindau (VHL) protein binds to HIF-1α and targets it to proteasome for 
degradation, mediated by ubiquitination of HIF-1α by the E3 ubiquitin ligase [143]. 
Ubiquitination sites are three lysine residues at positions 532, 538 and 547 [144]. Thus, 
HIF-1α is rapidly degraded under normoxic conditions - a half-life time is in the ten-
minute range [145]. Ubiquitination and degradation of HIF-1α do not occur under 
hypoxic conditions when these proline residues are non-hydroxylated [146] (Figure 4).  
Additionally, hydroxylation of an asparagine residue at position 803 as observed under 
normoxic conditions by the asparaginyl hydroxylase FIH (factor inhibitory HIF) hinders 
the interaction of HIF-1α with the coactivators CBP/p300. On the other hand, the 
interaction of HIF-1α and CBP/p300 is enabled under hypoxic conditions, which 
promotes HIF-1 transactivation [147] (Figure 4).  
In this regard, PHD and FIH enzymes appear to be the main cellular oxygen sensors since 
they regulate directly HIF-1α stability and activity. The oxygen sensing mechanism of 
HIF-1α hydroxylation by both PHD and FIH relies on the enzymatic reaction which 
requires O2 as a substrate in addition to the cofactors α-ketoglutarate, Fe2+ and ascorbic 
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acid. The Km values of PHD and FIH for oxygen are appropriate to sense the oxygen 
concentration in the physiologic relevant range [127], [128].  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Regulation of HIF-1α in hypoxia  
Hypoxic regulation of the hypoxia-inducible factor-1α (HIF-1α) transcription factor is 
primarily through inhibition of degradation. Under normoxic conditions, HIF-1α 
undergoes rapid proteosomal degradation once it forms a complex with von Hippel–
Lindau tumor suppressor factor (VHL) and E3 ligase complex. This requires the 
hydroxylation of critical proline residues by a family of HIF-1α-specific prolyl 
hydroxylases (PHD-1,2,3), which requires O2 and several cofactors, including iron. 
Under hypoxic conditions, or when iron is chelated or competitively inhibited, proline 
hydroxylation does not occur, thus stabilizing HIF-1α and allowing it to interact with the 
constitutively expressed HIF-1β (aryl hydrocarbon nuclear translocator; ARNT). The 
HIF-1 complex then translocates to the nucleus and activates genes with hypoxia-
responsive elements in their promoters. bHLH, basic helix-loop-helix; CBP, cAMP 
response element binding protein; FIH, factor inhibiting HIF-1α; PAS, PER-ARNT-SIM; 
TAD, transactivation domain. [148] 
 
1.2.4.3 Impact of reactive oxygen species on HIF regulation 
Reactive oxygen species are important mediators of cellular signaling which affect HIF 
induction under normoxic and hypoxic conditions [149]. The possible ROS sources 
related to oxygen sensing include mitochondria and NAD(P)H oxidases (Figure 5).  
Introduction 
 23
ROS derived from the electron transport chain of mitochondria under hypoxic conditions 
have been demonstrated to increase stability of HIF-1α [150], [151]. This observation 
was further explored, and was related to mitochondria derived ROS-dependent activation 
of kinases p38α MAPK. Under hypoxic conditions, mitochondrial ROS stimulates p38α 
MAPK activity which likely phosphorylates HIF-1α at TAD, thereby enhancing the 
binding of the coactivator CBP to HIF-1α [152]. Another possibility is that ROS interfere 
with the regulation of PHD or FIH hydroxylases, by limiting the availability of free Fe2+ 
by oxidation of free Fe2+ to Fe3+.  Fe3+ generated during the hydroxylation reaction of 
PHD is reduced to Fe2+ by ascorbic acid which is a further potential target of ROS [153]. 
In contrast, hydroxyl radical generation from hydrogen peroxide by the Fenton reaction 
in the ER activates PHD, thereby destabilizing HIF-1α [154]. 
Interactions between HIF-1α and particular ROS derived from NADPH oxidase have 
also been described. However, both HIF-1α−inhibiting and HIF-1α−inducing effects of 
ROS derived from NADPH oxidases have been observed in different cellular contexts 
[155], [156], [157], [158].  
The ROS-dependent induction of HIF-1α by Ang II-induced NADPH oxidase was 
mediated by enhanced cap-dependent translation of HIF-1α via activation of the 
phosphatidylinositol 3-kinase (PI3K)/Akt pathway [159], [160]. The study from Page et 
al. [160] further suggested that possible mechanism by which Ang II and ROS could 
increase the rate of HIF-1α translation involves activation of eukaryotic translation 
initiation factor 4F (eIF-4F) or the ribosomal S6 protein by the PI3K/p70S6K/mTOR 
pathway.  
On the other hand, strong oxidative stress appears to have an inhibitory effect on HIF-1α. 
Huang et. al. showed that treatment of HeLa cells with 1mM H2O2 for 20min led to a 
rapid decrease of HIF-1α abundance [123].        
Reactive oxygen species also affect the cellular redox systems, including thioredoxin, 
particularly cytoplasmic Trx1 [116]. Trx1 similarly as redox factor-1 (Ref-1) in reduced 
state stimulates HIF-1α activity by recruitment of cofactors CBP/p300 [161], [123]. In 
this context, the sulfhydryl groups of conserved cystein residues of HIF-1α (C800) and of 
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HIF-2α (C844) appear to be important. Additionally, protein stabilization of HIF-1α by 
Trx-1 has been suggested by inhibition of VHL and HIF-1α binding [162].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: ROS in oxygen sensing 
Hypoxia stimulates ROS generation by mitochondria or NADPH oxidases. ROS may 
regulate HIF-1α stability and activity directly by alteration of the HIF-1α redox state or 
indirectly. The indirect effect of ROS on HIF-1α is mediated by activation of mTOR 
dependent translation of HIF-1α, by activation of different kinases (e.g. MAPK) 
phosphorylating HIF-1α, by oxidation of Trx1 and Ref1 or other activators of HIF-
1α and by effecting PHD/FIH activity. The regulation of PHD/FIH activity by ROS may 
depend on oxidation of cofactors, such as Fe2+ and ascorbate, important for the function 
of these enzymes. An HIF-independent mechanism of oxygen sensing is represented by 
ROS-mediated regulation of redox state sensitive K+-channels leading to the 
depolarization of the cell membrane.          
 
1.3 Nuclear factor (erythroid-derived 2)-like 2  
1.3.1 Regulation of Nrf2 stability and activity 
Nuclear factor (erythroid-derived 2)-like 2 (Nrf2), is a redox state-dependent 
transcription factor that is activated under different stress conditions, such as oxidative 
stress. Nrf2 induces the expression of enzymes that exert a cytoprotective role when cells 
are exposed to oxidative or electrophilic compounds (Figure 6). This adaptive response is 
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mainly regulated by an interaction between Keap1 (Kelch-like ECH-associated protein 1) 
and Nrf2, in which the exposure to reactive molecules is sensed by Keap1 [163], [164]. 
The interaction between Keap1 and Nrf2 is likely mediated by disulfide bridges and by 
non covalent bonds between specific structural domains of both proteins [165], [166] In 
the Keap1-Nrf2 complex, Keap1 serves as a bridge between Nrf2 and the subunit of 
Cullin 3-based E3-ubiquitin ligase holoenzyme [167], [166], [168], [164]. However, 
Keap1 negatively regulates Nrf2 not only by enhancing its rate of proteasomal 
degradation but also by altering its subcellular distribution. In fact, Nrf2-Keap1 
heterodimer associates in cytosol with actin cytoskeleton under the “non-stress 
conditions” [169]. A disruption of Keap1-actin complex leads to translocation of Nrf2 
into nucleus [165].  
Nrf2 protein consists of six Neh (Nrf2-ECH homology) domains - each domain is 
characterized by specific physical-chemical properties based on amino acids sequence 
and on conformation. Neh2 domain structure is common among different species and it is 
responsible for binding Nrf2 to double glycine repeat (DGR) domain of Keap1, and 
consequently lysine residues inside of this domain are ubiquitinated by Cullin 3-based 
ligase [170]. Oxidative or electrophilic compounds alter the redox state of Keap1 
cysteines and thus diminish Nrf2 binding and ubiquitination [166]. Another mechanism, 
partially independent on oxidative/electrophilic stimuli, leading to Nrf2 dissociation from 
Keap1 is based on the phosphorylation of particular serine residue(s) of Nrf2 [171]. For 
example, phosphorylation of Ser-40 by protein kinase C has been shown to stimulate 
Nrf2 release from Keap1 and consequently increase Nrf2 abundance in the nucleus [172].  
1.3.2 Nrf2 target genes 
Nrf2 posses redox insensitive nuclear signal sequences in the area of the leuciner zipper 
motif [173]. This sequence enables Nrf2 to translocate into the nucleus, where it binds 
with its leuciner zipper domain to a cis-acting enhancer called the antioxidant response 
element (ARE) located in the regulatory DNA region of its target genes. Once inside the 
nucleus, Nrf2 dimerises with small Maf proteins leading to binding Nrf2 to ARE of the 
target genes and their transcriptional induction [174], [175], [176]. Enhancement of Nrf2-
mediated transcription has also been demonstrated by other proteins, in particular from 
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the Jun protein family (c-Jun, Jun-B, Jun-D) that can bind as a dimer with Nrf2 to the 
ARE sequences of the target genes [177].   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Mechanisms of Nrf2 activation 
Reactive compounds such as ROS and electrophiles disrupt the interaction between Nrf2 
and Keap1, likely by changing the redox state of specific cysteine residues. Keap1 in 
interaction with Nrf2 serves as a stress sensor which connects the Cullin 3-based E3-
ubiquitin ligase with Nrf2. In non-stress conditions, the Nrf2-Keap1 complex is bound to 
the actin cytoskeleton and Nrf2 is targeted to rapid proteasome degradation. Disruption of 
Nrf2-Keap1 interaction by reactive molecules leads to translocation of Nrf2 into the 
nucleus, were it dimerizes with the small Maf protein and binds to the antioxidant 
responsive element (ARE) in the regulatory DNA sequence of target genes. In addition, 
Nrf2 activation is enhanced by phosphorylation of specific serine residues. Also, kinases 
responsible for Nrf2 phosphorylation may be activated by different reactive molecules. 
Similarly to HIF-1α, the transcriptional activity of Nrf2 is stimulated by the coactivators 
CBP or p300. Nrf2 enhances the transcription of genes that code enzymes important in 
metabolism of xenobiotics and in defense against oxidative stress. [164]  
 
Nrf2 induces the expression of genes encoding cytoprotective enzymes. These are either 
enzymes that play an important role in metabolism of xenobiotics, such as glutathione-S-
transferases, epoxide hydrolase, UDP-glucuronosyltransferase, aldehyde dehydrogenase, 
aldo-keto reductase or typical antioxidative enzymes, such as NADPH-quinone 
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oxidoreductase, glutathione reductase, peroxiredoxin, catalase, superoxide dismutase, 
glutathione peroxidase, thioredoxin and thioredoxin reductase [164]. Nrf2 is 
cytoprotective factor since it increases the resistance to chemically induced injuries and 
protects cells and organisms from various diseases. In this context, Nrf2 may prevent 
cancerogenesis by detoxification of cancerogenic agents [178], [179], [180], [181]. On 
the other hand, uncontrolled Nrf2 activation is a characteristic of some types of cancer 
cells [182]. Several cancer cell lines or primary tumor cell types display somatic 
mutations in the Nrf2 or Keap1 gene that are accompanied with non-efficient Nrf2 
protein degradation due to diminished Nrf2-Keap1 interaction. For example, single amino 
acid mutation in the Neh2 region of Nrf2 have been detected in LK2 and EBC1 lung 
cancer cell lines [183]. A549 and H1395 lung cancer cell lines display single amino acid 
mutation in the first Kelch region (Kelch are structural motifs of the DGR domain) of 
Keap1 [184], [185]. Consequences of the insufficient Nrf2 degradation are aberrant 
elevation of the expression of cytoprotective enzymes that in turn attenuates apoptosis 
and leads to uncontrolled and disorganized cell growth that are typical hallmarks for 
malignant cells (Figure 7).               
1.4 Thioredoxin system 
1.4.1 Thioredoxin 
Thioredoxin (Trx), a target gene of Nrf2 [186], [187], is a small (12kDa) ubiquitous 
protein that acts as oxidoreductase enzyme by facilitating the reduction of other proteins 
by cysteine thiol disulfide exchange. Trx and Trx-related proteins have an active center 
characterized by two cysteine residues (-Cys-Gly-Pro-Cys-) and a specific tertiary 
structure termed thioredoxin fold [188], [101]. The mechanism of protein reduction by 
Trx involves a transient mixed disulfide intermediate and fast thiol disulfide exchange in 
a hydrophobic environment. The reaction is reversible and thioredoxin may either break 
or form disulfides depending on the redox potential of its substrate. However, the very 
low redox potential of reduced Trx (Trx-(SH)2) usually ensures that Trx-(SH)2 is the 
major dithiol reductant in the cytosol [189], [101]. The human Trx may form a 
functionally inactive homodimer that is implicated to have a regulatory function. There 
are several isoforms of thioredoxins and thioredoxin related proteins [101]. The most 
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abundant isoform is Trx1 that is predominantly localized in the cytosol. Trx2 is another 
important thioredoxin isoform that contains a mitochondrial translocation signal and thus 
is mainly localized in mitochondria [190]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Dual role of Nrf2 in cancerogenesis 
In “normal” cells, Nrf2 expression is increased upon stimulation (stress) by different 
reactive compounds such as ROS and electrophiles, whereas under “non-stress” 
conditions Nrf2 is rapidly degraded by the proteasome pathway. Nrf2 induction leads to 
enhanced expression of cytoprotective enzymes that play an important role in the 
metabolism of xenobiotics, ROS and in the elimination of their reactive metabolites. 
These effects are suggested to counteract carcinogenesis.  
On the hand, some cancer cell types display an aberrant induction of Nrf2. This is caused 
by insufficient degradation of Nrf2 which is based on mutations of amino acids in Nrf2 or 
its interaction partner Keap1. The aberrant induction of Nrf2 strongly enhances 
expression of cytoprotective enzymes which leads to the weakening of apoptosis and to 
uncontrolled and disorganized cell growth that are characteristics of malignant 
transformation.  
 
1.4.2 Thioredoxin reductase 
The oxidoreductase function of thioredoxins is maintained by another oxidoreductase 
enzyme termed thioredoxin reductase (TrxR) [191]. TrxR enzymes are NADPH-
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dependent homodimeric oxidoreductases reducing the active disulfide site in oxidized 
Trx. TrxR contains selenium in the form of selenocysteine that is incorporated in the 
amino acid chain during translation [192]. Selenocysteine is localized in the active site of 
TrxR and its oxidized form (selenenylsulfide) can be reduced to a selenolthiol only by the 
redox active dithiol of another TrxR in the dimer of this enzyme. Thus, the homodimeric 
form of TrxR is critical for its function [193]. There are several isoforms and splice 
variants of thioredoxin reductases, however they do not appear to have a high specifity 
for any particular type of thioredoxin. In general, a striking characteristic of mammalian 
TrxRs is the wide substrate specificity and the direct reduction of different protein 
disulfides, many low molecular weight disulfide compounds and non-disulfide 
compounds The wide substrate specificity can be explained by the unique and easily 
accessible Selene-containing redox active site [189], [101].  
1.4.3 Function of the thioredoxin system    
The thioredoxin system is the functional connection between Trx and TrxR. The 
thioredoxin 1 system is the most abundant system in mammalian cells. It consists of the 
cytosolic Trx1 and TrxR1. The function of the thioredoxin system, in particular the Trx1 
system, is essential for many physiological processes. Together with the glutathione 
system, the Trx system is the most important “redox buffer” maintaining the intracellular 
environment in reduced state. Thioredoxins generally protect intracellular proteins from 
inactivation via oxidative formation of intra- or inter-molecular disulfides [101]. 
Furthermore, thioredoxins serve as electron carriers necessary for the catalytic cycles of 
biosynthetic enzymes, such as ribonucleotide reductases, methionine sulfoxide reductases 
and sulfate reductases [194], as well as enzymes important for protein folding, such as 
protein disulfide isomerases [195]. Thioredoxins also act through the regulation of the 
thiol redox state and direct binding to other molecules as signaling messengers. For 
instance, reduced Trx1 binds to ASK1 refelecting the redox-dependent regulation of 
apoptosis that is inhibited under conditions of reduced Trx when there is no oxidative 
stress [113],. Additionally, as described in chapter 1.2.3, Trx1 activates several 
transcription factors in a redox state-dependent manner among them are HIF-1α[116], 
AP-1 factor [118], [119] and NF-κB [117]. 
Aims of the work 
 30
2. Aims of the work 
Part I 
NADPH oxidase 1 and NADPH oxidase 4 are enzymatic complexes that play an 
important role in cellular signaling by generation of ROS. The core subunits of NADPH 
oxidase 1 and 4 are NOX1 and NOX4, respectively. The expression, regulation and 
subcellular localization of NOX1 and NOX4 are not fully explored because of the lack of 
the availability of specific antibodies against these proteins. Thus, the aims in the first 
part of this study were: 
1. To analyse immunoreactive proteins detected with different commercially available 
and custom made antibodies against NOX1 and NOX4, i.e. to select most suitable 
antibody for detection of NOX1 and NOX4 proteins. 
2. To characterize the subcellular localization of NOX1 and NOX4 employing these 
antibodies. 
3. To identify putative NOX1 and NOX4 proteins by different proteomic tools such as 
HPLC/2D-GE protein purification followed by MALDI-TOF MS analysis. 
4. To design synthetic siRNAs for the efficient knock-down of NOX1 and NOX4 as a 
tool for testing the antibodies and for functional studying NOX1- and NOX4-dependent 
ROS generation. 
 
Part II 
The NOX1 containing NADPH oxidase is a significant source of ROS in human 
adenocarcinoma A549 cells. ROS are involved in the regulation of the transcription 
factors HIF-1 and Nrf2. A possible link between these transcription factors may represent 
the Nrf2 dependent target gene thioredoxin 1 (Trx1) that is known to induce HIF-1α. 
Both the regulation of HIF-1 and Nrf2 are affected by hypoxia, reoxygenation and 
intermittent hypoxia. These conditions are characterized by fluctuations of ROS levels, 
involving NADPH oxidases as relevant ROS sources in the regulation of HIF-1 and Nrf2.  
In particular, intermittent hypoxia may represent a situation where a cross-talk between 
HIF-1 and Nrf2 occurs. The specific aims of the second part of the work were: 
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1. To analyse the expression of NOX1 and the transcription factors HIF-1 and Nrf2, as 
well as its target Trx1 under different stages of continuous hypoxia, reoxygenation and 
intermittent hypoxia, in the human adenocarcinoma A549 cells.  
2. To analyse possible cross-talk(s) between NOX1, Nrf2, Trx1 and HIF-1α.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Materials and Methods 
 32
3. Materials and Methods 
3.1 Materials 
3.1.1 Materials and instruments  
Western blot and protein concentration measurement 
Glasses for gels, combs, electrophoresis chambers, electroblotting chambers, power 
supplies, blotting paper (all from Bio-Rad, Hercules, CA, USA), polyvinylidene fluoride 
(PVDF) membrane (Millipore Corporation, Billerica, MA, USA), chemiluminiscence 
imager (FluorchemTM IS-8900) (Alpha Innotech, San Leandro, CA, USA), Immuno 96 
MicroWell™ Plates (96 well plate) (Nunc, Roskilde, Denmark), spectrofluorometer (FL-
600) (BioTek Instruments GmbH, Bad Friedrichshall, Germany) 
Agarose gel electrophoresis 
Gel chamber, traces, combs (Biometra GmbH, Goettingen, Germany)   
HPLC  
Nanonsep 10K/Microsep 3K (ultra-filters) (Pall life Sciences, Ann Arbor, MI, USA), 
QIAquick Spin Columns (DNA binding column) (Qiagen GmbH, Hilden, Germany), 
MonoQ (CV ≈ 1ml, column for AEC) (GE Healthcare, AmershamTM, Buckinghamshire, 
UK), Symetry 300 (C8, column for RPC) (Waters, Milford, MA, USA), sample syringe 
of 2ml (Hamilton Company, Nevada, USA), HPLC system Agilent 1100 Series (Agilent 
Technologies, Santa Clara, CA, USA)  
 
3.1.2 Chemical agents 
Trifluoroacetic acid (TFA), MG132 (Z-Leu-Leu-Leu-al), diphenyleneiodonium chloride 
(DPI), protease inhibitor cocktail, Triton X-1000, bromophenol blue, glycerol, porcine 
skin gelatin, Tryptone, yeast extract (all from Sigma-Aldrich, St. Louis, MO, USA), 
agarose (broad range), Tris, NaCl, HEPES, dimethylsulfoxide (DMSO), Rotiphorese Gel 
30, Roti-Block (all from Carl Roth GmbH, Karlsruhe, Germany), 
ethylenediaminetetraacetic acid (EDTA), HCl (36%), NaOH, sodium dodecyl sulphate 
(SDS), urea, methanol, acetonitrile (ACN), acetic acid (all from Merck KGaA, 
Darmstadt, Germany), prestained SDS-PAGE protein marker (PageRuler), DNA ladder 
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(NoLimits) (all from Fermentas Life Sciences, Burlington, Ontario, Canada), Enhanced 
Chemiluminiscence (ECL) plus (GE Healthcare, AmershamTM, Buckinghamshire, UK), 
Coomassie® Brilliant Blue G 250 (powder for Coomassie Brilliant Blue), ethidium 
bromide (all from SERVA Electrophoresis GmbH, Heidelberg, Germany), Lipofectamin 
2000 (Invitrogen, Carlsbad, CA, USA) 
 
3.1.3 Buffers 
Western blot  
● 4x Laemmli sample buffer: 0.25 M Tris (pH adjusted with HCl to 6.8), 8% of SDS, 
40% of glycerol, adjusted with dest. H2O 
● Collecting buffer: 0.625 M Tris (pH adjusted with HCl to 6.8) 
● Separating buffer: 1.125 M Tris, 30% of sacharose, pH adjusted with HCl to 8.8 
● 10x NET: 1.5 M NaCl, 50mM EDTA (pH adjusted with NaOH (25%) to 8), 0.5 M Tris 
(pH adjusted with HCl to 7.4), 0.5% of Tx-100 
● Blocking buffer: 1x NET with 0.25% porcine skin gelatin 
● Transfer buffer: 25 mM Tris, 192 mM glycine, 20% of methanol, 0.01% of SDS  
● Coomassie Brilliant Blue (CBB): 0.1% of Coomassie® Brilliant Blue G 250, 50% of 
methanol, 10% of acetic acid, adjusted with dest. H2O. 
● CBB destaining buffer: 50% of methanol, 10% acetic acid, adjusted with dest. H2O 
HPLC 
● AEC: buffer A: 20 mM Tris (pH adjusted with HCl to 8.8), buffer B: 1 M NaCl, 20 
mM Tris (pH adjusted with HCl to 8.8) 
● RPC: “buffer” A: H2O, 0.1% TFA, “buffer” B: ACN, 0.07% TFA 
DNA agarose gel electrophoresis 
● 10x TAE buffer for agarose gels: 0.4 M Tris, 0.4 M acetic acid, 10 mM EDTA (pH 
adjusted with HCl to 8.0) 
● Agarose gel (1%): 10% of 10x TAE, 1% of agarose, 0.5 μg/ml of ethidium bromide   
● DNA Loading buffer: 0.01% of bromophenol blue, 40% of glycerol, 10% of 10x TAE 
buffer 
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3.1.4 Antibodies 
HIF-1α (LS-B495, Lifespan Biosciences, WA, USA), HIF-1α (BD Biosciences, San 
Diego, CA, USA), Nrf2 (H-300), Trx1 (FL-105), MOX1 H-15, MOX1 H-75, NOX4 N-
15, NOX4 H-300, PGK1/2 (E-20), Na+/K+-ATPase α (H-3), Lamin B (C-20), (all from 
Santa Cruz Biotechnology, Santa Cruz, CA, USA), NOX1jh, NOX4jh (both from 
laboratory of Dr.J.Hänze, University Giessen), NOX1ab55831, β-actin (AC-15) (both 
from Abcam, Cambridge, UK), NOX1wch (kind gift from Dr. W. Chamulitrat, 
University Heidelberg, Germany), mAb54.1 (kind gift from Prof.W.Kummer, University 
Giessen, The antibody was generated for laboratory of Dr.J.Burrit, Montana State 
University, Bozeman, USA.), monoclonal anti-HA (hem agglutinin) antibody (Clone 
HA-7) (Sigma-Aldrich, St. Louis, MO, USA), Cytokeratin (MNF16) (antibody reacts 
with cytokeratin 5, 6, 8, 17) (DakoCytomation, Denmark), secondary antibody (anti-
rabbit, -goat, -mouse) conjugated to horseradish peroxidase (HRP) (Thermo Scientific, 
Pierce Biotechnology, Rockford, IL, USA) 
 
3.1.5 Oligonucleotide sequences 
Primer sets (+, forward; -, reverse) for PCRs 
NOX1+: 5’-CTC TCT CCT GGA ATG GCA TC-3’ 
NOX1–: 5’-TGG AAA ACA TCC TCA CTG GC-3’  
NOX4+: 5′-AAA CTT CTC TTC ACA ACTG TTC CTG-3′ 
NOX4-: 5′-TGG TAA GGA AAT ATT CTG AGA GCTG-3′ 
Trx1+: 5’-CAG ATC GAG AGC AAG ACT GCT TTT C-3’  
Trx1-: 5’-CTT ATT GGC TCC AGA AAA TTC ACC C-3’  
Nrf2+: 5’-TGC TTT CATA GCT GAG CCC AGT ATC-3’ 
Nrf2-: 5’-TCC ATA GCT GGA AGA TTC CAC TGAG-3’ 
HIF-1α+: 5’-AAA GGG TAA AGA ACA AAA CAC ACAG-3’       
HIF-1α+: 5’-TAA AGG AAT TTC AAT ATT TGA TGGG-3’       
β-actin+: 5’-TAT CCA GGC TGT GCT ATC CCT GTA C-3’  
β-actin-: 5’-TTC ATG AGG TAG TCA GTC AGG TCC C-3’  
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Oligonucleotide sequences for cloning reporter gene plasmids 
PGK-HRE:  
Forward Nhe I: 5’-CTA GCG CGT CGT GCA GGA CGT GAC AAA TAG CGC GTC 
GTG CAG GAC GTG ACA AAT AGC GCG TCG TGC AGG ACG TGA CA AAT-3’  
Reverse Xho I: 5’-TCG ACT TTG TCA CGT CCT GCA CGA CGC GCT ATT TGT 
CAC GTC CTG CAC GAC GCG CTA TTT GTC ACG TCC TGC ACG ACG CG-3’ 
NQO1-ARE:  
Forward Nhe I: 5’-CTA GCA GTC ACA GTG ACT CAG CAG AAT CTG-3’   
Reverse Xho I: 5’-TCG ACA GAT TCT GCT GAG TCA CTG TGA CTG-3’ 
 
3.1.6 siRNAs  
siRNAs sequences (+, forward; -, reverse)  
si-con+: 5’-UAG CGA CUA AAC ACA UCAA dTdT -3’ 
si-con-: 5’-UUG AUG UGU UUA GUC GCUA dTdT-3’ 
si-NOX1+: 5’-CCU GAG GGG CAC CUG CUCA dTdT-3’  
si-NOX1-: 5’-UGA GCA GGU GCC CCU CAGG dtdT-3’ 
si-NOX4+: 5′-CCU CUU CUU UGU CUU CUAC dTdT-3′ 
si-NOX4-: 5′-GUA GAA GAC AAA GAA GAGG dTdT-3′ 
p22-phox+: 5’-CAU GAC CGC CGU GGU GAAG dTdT-3’ 
p22-phox-: 5’-CUU CAC CAC GGC GGU CAUG dTdT-3’ 
si-Nrf2+: 5’-GUA AGA AGC CAG AUG UUAA dTdT-3’ 
si-Nrf2-: 5’-UUA ACA UCU GGC UUC UUAC dTdT-3’ 
si-Trx1+: 5’-UGA UCA ACC CUU UCU UUCA dTdT-3’ 
si-Trx1-: 5’-UGA AAG AAA GGG UUG AUCA dTdT-3’  
 
3.1.7 Plasmids 
Plasmid isolation: Maxiprep Kit (MACHEREY-NAGEL GmbH, Düren, Germany) 
Used plasmids: pcDNA3.1+ (Invitrogen, Carlsbad, CA, USA), pCMV-HA (Clontech, 
Mountain View, CA, USA), pIRES, pGL3-TK (both from Promega, Promega 
Corporation, Madison, WI, USA) 
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3.1.8 Cell culturing  
3.1.8.1 Bacteria, mediums for bacteria culturing and transformation 
Bacterial strains: E.Coli TOP10 bacterial strain from Invitrogen (Invitrogen, Carlsbad, 
CA, USA) was used for plasmid transformation. Genotype of the strain was “F- mcrA 
Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ(araleu) 7697 galU 
galK rpsL (StrR) endA1 nupG”. 
Transformation medium: 2% of Tryptone, 0.5% of yeast extract, 10mM NaCl, 2.5mM 
KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM Glucose, pH = 7.3 
Agar plates: 7.5g bactoagar, 500ml LB medium, 500μl ampicillin (stock 100μg/ml)      
Luria Bertani (LB) medium: 1% of Tryptone, 0.5% of yeast extract, 10mM of NaCl, pH 
= 7.3 
 
3.1.8.2 Mammalian cells and cell culturing mediums 
A549  
The human lung adenocarcinoma A549 cell line was obtained from the American Type 
Culture Collection (Manassas, VA, USA). Cells were cultured in D-MEM/F-12 medium 
(Gibco, Invitrogen, Carlsbad, CA,USA) supplemented with 10% fetal bovine serum 
(Greiner BioOne, Frickenhausen, Germany), non-essential amino acids (1mM), penicillin 
(1U/ml) with streptomycin (100μg/ml), L-glutamine (2mM), and vitamins (1×) (all 
supplements were from Gibco, Invitrogen, Carlsbad, CA,USA).  
 
CaCo2  
The colorectal carcinoma cell line (CaCo2) was obtained from the American Type 
Culture Collection (Manassas, VA, USA). Cells were cultured in DMEM medium 
(containing 4.5g/l glucose, L-glutamine, pyruvate) supplemented with 10% fetal bovine 
serum (Greiner BioOne, Frickenhausen, Germany), 25mM HEPES (Carl Roth GmbH, 
Karlsruhe, Germany), non-essential amino acids, (1mM), penicillin (1U/ml) with 
streptomycin (100μg/ml) (DMEM and supplements were from Gibco, Invitrogen, 
Carlsbad, CA, USA).  
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HUVEC  
These endothelial cells, kindly provided by Dr. K. Mayer (University of Giessen Lung 
Center (UGLC), Justus-Liebig-University of Giessen, Giessen, Germany), were isolated 
from human umbilical veins (Human Umbilical Veins Endothelial Cells). Briefly, cells 
obtained from collagenase digestion were washed, pooled, centrifuged for 10 min at 
210g, and resuspended in fresh medium. Before splitting, cells were grown for 2 to 3 
days on T 75 culture flasks coated with gelatine in an atmosphere of 95% O2 and 5% 
CO2. For the experiments HUVECs from passage 2 and 3 were used. Cells were always 
cultured in Endothelial Cell Growth Medium (containing 10ml FCS, 2ml ECGS/H, 0.1ng 
EGF/ml, 0.1ng bFGF, 0.1μg Hydrocortison/ml in 500ml of medium) supplemented with 
Supplement Mix C-39215 (all from PromoCell GmbH, Heidelberg, Germany).     
 
Cell culturing medium for transfection experiments 
In all transfection experiments, OPTI-MEM (Gibco, Invitrogen, Carlsbad, CA, USA) was 
used instead of cell culture medium for transient incubation of cells with siRNA or 
plasmid.   
 
3.2 Methods 
3.2.1 Biochemical methods 
3.2.1.1 Subcellular fractionation 
A) Isolation of cytosol, nuclei, membranes and cytoskeleton 
The cytosolic, nuclear, membrane and cytoskeleton fractions were isolated from cells 
according to the protocol of the Complete Cell Fractionation Kit (PromoKine, PromoCell 
GmbH, Heidelberg, Germany). One modification of the protocol was that DTT was not 
added to of the extraction buffers, since DTT would interfere with the assay used for 
protein concentration measurement. The isolated fractions were directly mixed with 4x 
Laemmli sample buffer in the ratio of 3:1 or dissolved in 1x Laemmli sample buffer.       
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B) Separation of Tx-100 soluble and insoluble fraction 
Cells were washed with PBS, scraped in a PBS containing protease inhibitor cocktail, 
transferred to eppendorf tubes and on ice lysed by sonication (four times for five 
seconds). Subsequently, Tx-100 was added into the cell lysate with a final concentration 
of 1%. After incubation of the cell lystate in ice for 30 minutes, the samples were 
centrifuged for 15 min at 14000g. The pellet (Tx-100 insoluble fraction) was directly 
dissolved in 1x Laemmli sample buffer and the supernatant (Tx-100 soluble fraction) was 
mixed with 4x Laemmli sample buffer in a ratio of 3:1. In order to analyse the effect of 
Tx-100 on cell fractionation, a sample without treatment by Tx-100 was used as a 
negative control.  
C) Isolation of plasma membrane 
The cytosolic, total membrane (containing all membranes and also cytoskeleton) and 
plasma membrane fractions were isolated from cells according to the protocol of the 
Membrane Protein Extraction Kit (PromoKine, PromoCell GmbH, Heidelberg, 
Germany). The isolated fractions were directly mixed with 4x Laemmli sample buffer in 
a ratio of 3:1 or dissolved in 1x Laemmli sample buffer.       
D) Isolation of nuclei 
The cytoplasmic, nuclear soluble and nuclear insoluble fractions were isolated according 
to the protocol of the Nuclear and Cytoplasmic Extraction Reagent (Thermo Scientific, 
Pierce Biotechnology, Rockford, IL, USA). The isolated fractions were directly mixed 
with 4x Laemmli sample buffer in a ratio of 3:1 or dissolved in 1x Laemmli sample 
buffer. 
E) Subcellular fraction of samples for HPLC 
Since the composition of commercially available buffers used in the kits for subcellar 
fractionation was not known, the fractions could not be applied directly for HPLC. Also 
acetone precipitation of the proteins from the subcellular fractions was not suitable for 
further HPLC based analysis, because the acetone precipitate was difficult to dissolve in 
any buffer. Thus, self-made crude subcellular fractionation was performed as desribed:  
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Cells were scraped in 20mM Tris (pH was adjusted with HCl to 8.0) containing a 
protease inhibitor cocktail, homogenized on ice by a Dounce homogenizator and 
gradually centrifuged at 1050g, 14000g, 110000g. The 1050g pellet was called as nuclei 
enriched fraction, the 14000g pellet as cytoskeleton and mitochondria enriched fraction, 
the 110000g pellet as membrane enriched fraction and 110000g supernatant as cytosol 
enriched fraction. The fractions containing the highest amount of the protein of interest 
(checked by Western blot) was used for further HPLC purification. 
 
 3.2.1.2 Protein concentration measurement 
The BCA protein assay kit (Thermo Scientific, Pierce Biotechnology, Rockford, IL, 
USA) was used for the measurement of the protein concentration. This method is based 
on peptide bonds mediated reduction of Cu2+ to Cu1+ that interacts with bicinchoninic 
acid (BCA) generating a purple-colored product and it is useful for the measurement of 
protein concentrations in buffers containing various chemical agents including SDS and 
Tx-100. Thus, samples dissolved in 1x Laemmli sample buffer and buffer containing 1% 
of Tx-100 were directly applicable for the protein concentration measurement. 
Preparation of standards (differently diluted bovine serum albumin), incubation 
conditions, spectrophotometric measurement and calculation of protein concentration 
were performed according to the company’s protocol. The absorbance of the purple color 
product was measured on a 96 well plate at 492nm with a spectrofluorometer (FL-600). 
As background, values of absorbance of relevant buffer(s) were used.  
 
3.2.1.3 Western blot 
After protein concentration determination, samples were mixed with β-mercaptoethanol 
(final concentration of 2.5%) and trace amount of bromophenol blue (final concentration 
of ca. 0.01%) and stored at -80°C. Immediately before loading onto the gel, samples were 
heated at 85°C for 5min and mixed. The gel electrophoresis, i.e. sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE), was performed with self-made 8% or 
10% or 12% polyacrylamid gel at constant voltage of approx. 100-120V. The run of the 
gel was controlled by separation of prestained molecular weight marker. 
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Proteins in the gel were transferred to a PVDF membrane by semi-dry electroblotting. 
The PVDF membrane was wetted with methanol and then placed onto the gel. Two 
layers of with transfer buffer soaked 3mm blotting papers were placed on and under  the 
membrane-gel sandwich in the electroblotting chamber. The electroblotting was 
performed at a constant current of approx. 2mA/cm2 for 90min. 
After transfer of proteins, the PVDF membrane was blocked with 1x NET buffer 
containing 0.25% of porcine skin gelatin for 1 hour. The the PVDF membrane was 
incubated with the primary antibody diluted in the same buffer containing gelatin 
overnight at 4°C. The second day, the PVDF membrane was washed with 1x NET buffer 
three times for 10 minutes and subsequently incubated with the appropriate secondary 
antibody conjugated to HRP for 2 hours. The membrane was then again washed with 1x 
NET buffer three times for 10 min. Immunoreactive bands were visualized on the 
membrane by addition of the ECLplus reaction mixture employing a chemiluminiscence 
imager (FluorchemTM IS-8900). 
 
3.2.1.4 HPCL protein purification 
After subcellular fractionation, pellets (1050g or 14000g or 110000g) containing protein 
of interest were dissolved in chromatographic buffer A containing 6M urea and passed 
through a DNA binding column and placed on ice. If the supernatant (110000g) was 
used, it was mixed with urea to a final concentration of 6M and again passed through the 
DNA binding column and placed on ice. Samples containing urea were mixed with 
chromatographic buffer A in a ratio of 1:5 and immediately used for AEC.  
A) Anion exchange chromatography 
The anion exchange chromatography (AEC) was performed with a strong anion exchange 
chromatography column (MonoQ, column volume of 1ml) applying a Tris-HCl based 
buffer system and a NaCl gradient based elution with a buffer flow rate of 1ml per 1min. 
After sample injection into the sample loop, the column was equilibrated until the initial 
peak representing unbound material (i.e. flow-through (FT) decreased to base line level. 
Then, the gradient for the elution of proteins from the column by buffer B (0-100% of 
buffer B) was started and the individual fractions were collected per minute (1 minute ≈1 
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fraction) for approx. 30 min. Proteins eluted from the column were detected at 280 and 
220nm.  
An aliquot (usually 10-20%) from each fraction including the FT was precipitated by 
acetone (final concentration of 80%), solubilized in 1x Laemmli sample buffer and 
analysed by Western blot.        
B) Reverse phase chromatography  
Reverse phase chromatography (RPC) was performed with a silica based C8 column 
(Symetry300) applying “buffers” (solutions) containing trace amount of TFA (max. 
0.1%) and an ACN gradient based elution with a buffer flow rate of 1ml per 1min. 
Relevant fractions from AEC were acidified by TFA to a final concentration of 0.1% and 
injected into the sample loop. The column was equilibrated until the initial peak 
representing FT decreased to base line. Then, the gradient for the elution of proteins from 
the column by “buffer” B (10-80% of “buffer” B) was started and individual fractions 
were collected per minute (1 minute ≈ 1 fraction) for approx. 60 min. Proteins eluted 
from the column were detected at 280 and 220nm.  
Fractions were evaporated in a vacuum centrifuge, dissolved in 1x Laemmli sample 
buffer and used for Western blot analysis.     
 
3.2.1.5 2D gel electrophoresis 
Samples were precipitated by acetone (final concentration of 80%), dried and analyzed 
by 2D-gel electrophoresis (2D-GE) (Department of proteomics).   
Briefly, 400μg of protein sample was dissolved in rehydration buffer and loaded onto an 
immobilized pH gradient (IPG) gel strip (pH range 3-10, 11 cm). After isoelectric 
focusing (IEF) the IPG gel strip was incubated with the equilibration stock solution, 
alkylated by iodoacetamide and loaded onto the top of a 12% SDS-polyacryl-amid gel. 
Protein separation efficiency according to the molecular weigh was checked by the same 
prestained molecular weight marker as for 1D SDS-PAGE (section 3.2.1.3). Proteins 
from the gel were transferred onto a PVDF membrane that was subsequently blocked by 
1x NET buffer with 0.25% porcine skin gelatin for at least 1 hour. The subsequent 
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procedures of incubation with antibodies and immunodetection were performed in the 
same way as described for Western blot (section 3.2.1.3).           
 
 3.2.1.6 MALDI-TOF MS 
The polyacryal-amid gel from SDS-PAGE was stained with Coomassie Brilliant Blue 
(CBB) and slices of the gel containing proteins of interest were analyzed by MALDI-
TOF MS (matrix assisted laser desorption/ionisation-time of flight mass spectrometry) 
analysis (Department of Proteomics). Alternatively, immunoreactive bands detected on 
the PVDF membrane were labeled and excised from the membrane for further MALDI-
TOF MS analysis. If proteins transferred onto the  PVDF membrane were subjected to 
MS analysis, the membrane was blocked with the non-protein containing polymeric 
solution Roti-Block instead of porcine skin gelatin. For CBB staining, the SDS-
polyacryal-amid gel was firstly incubated with gentle shaking for 1 hour in CBB solution 
and then destained until the protein bands were visible. In parallel with CBB staining of 
the gel, the same sample was usually used for Western blot analysis by the relevant 
antibody to show the presence of protein of interest in the gel. In order to make sure that 
the appropriate protein would be cut from the gel for further analysis, the whole area near 
to the expected size of the protein was cut in small gel slices and subjected to MALDI-
TOF MS. 
Briefly, gel slices were rinsed by ultrapure water and, by a solution of (NH4)HCO3/ACN 
(1:1) and by 100% ACN. Subsequently, trypsin digestion at 37°C was performed 
overnight. Peptides were extracted by 1% TFA containing octyl-glucopyranoside. 
Aliquots of peptide digests were mixed with a solution of 2,5-dihydrobenzoic acid, 
ACN/H3PO4 on a stainless steel target (Bruker Daltonik, Bremer, Germany) using a 
dried-droplet method. Peptide mass fingerprints (PMF) of tryptic digests were obtained 
by MALDI-TOF-MS using an Ultraflex TOF/TOF mass spectrometer (Bruker Daltonik). 
Peptide mass standards (Bruker Daltonik) were used for external calibration of the mass 
spectra. Mass spectra were acquired in a reflector mode using FlexControl 2.4 Software 
(Bruker Daltonik), and analysed by the FlexAnalysis software 3.0. The SwissPprot 
database employing the MASCOT 2.0 program was used for search of peptide masses to 
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identify the proteins. The versions used were SwissProt 48.8 or MSDB. The taxonomic 
category was “homo sapiens (human)” since human cells were analyzed. In addition to 
PMF, other main search parameters were set as follows: enzyme specifity: trypsin, fixed 
modification: carabamidometylation of cysteine, variable modification: oxidation of 
methionine, mass values: monoisotopic, protein mass: unrestricted peptide, peptide mass 
tolerance: +/-100 ppm, peptide charge state: 1+, max. missed cleavage: 1. Protein 
matches were assessed on the basis of the number of peptides matched to target protein. 
The intensity of these peptides was expressed as percentage of all submitted peptides, and 
MOWSE (molecular weight search) score greater than 60 (p<0.05) for MS data were 
regarded positive for protein identifications. The score threshold to achieve p<0.05 was 
set by Mascot algorithm and was based on the size of the database used in the search. 
Only proteins with the score higher than 60 and highest number of matching peptides in 
each Mascot search were accepted as successful indications.  
 
3.2.1.7 Reactive oxygen species measurement  
Total cellular reactive oxygen species (ROS) were measured as concentration of H2O2 by 
Amplex Red Hydrogen Peroxide/Peroxidase Assay (Invitrogen, Carlsbad, CA, USA). 
This method is based on the reaction of Amplex Red with H2O2 in the presence of HRP 
(included in kit) generating a red product (resorufin) that can be quantified by 
fluorescence measurement. Nanomolar concentrations of H2O2 in solutions can be 
sensitively measured using this kit.  
Cells on a six-well plate were washed with the kit reaction buffer, scraped into dark 
eppendorf tubes and briefly sonicated on ice (three times four seconds). An equal amount 
of sample and reaction mixture (prepared according to the product protocol) were mixed 
together on a 96 well plate and incubated protected from light for at least 30min at room 
temperature. Then, the fluorescence was measured at 595nm after excitation at 530nm 
using a spectrofluorometer (FL-600). Values of fluorescence were normalized to µg of 
protein in each sample. 
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3.2.1.8 Luciferase activity 
The activity of luciferase in cells transfected with ARE- and HRE-reporter plasmids was 
measured as relative light units (RLU) with the Luciferase Assay System according to the 
manufacturer’s protocol (Promega Corporation, Madison, WI, USA). In brief, cells were 
lysed with passive lysis buffer (100μl per well, 48 well plate), shaken for 15 min at room 
temperature, and frozen at -80°C. After thawing and measurement of the protein 
concentration, the components of the Luciferase Assay System were added to the aliquot 
of the sample on a 96 well plate, and the chemiluminescence was measured using a 
spectrofluorometer (FL-600). The values of RLU were normalized to µg of protein in 
each sample. 
 
3.2.2 Molecular biological methods  
3.2.2.1 Transformation of bacteria and isolation of plasmid  
Transformation of competent cells: For transformation of competent cells, i.e. E.coli 
TOP10, was performed with the heat shock method. The plasmid was gently mixed with 
one aliquot of the competent cells and incubated on ice for 30 min. Then the mixture was 
heated at 42°C for 1 min followed by immediate cooling on ice. Thereafter, the bacterial 
cells were cultured in 100μl SOC medium at 37°C for 1 hour. The transformed bacterial 
cells were spread over an ampicillin containing agar dish and incubated overnight at 
37°C. The successfully transformed cells formed colonies on the agar plates. 
Plasmid isolation: Plasmids isolation was performed with Maxiprep Kit (MACHEREY-
NAGEL GmbH, Düren, Germany). The colonies of transformed E.Coli TOP10 cells were 
picked and cultured in 200ml LB medium and grown up to a density of about 109 cells 
per ml. The cells were pelleted by centrifugation at 5800g for 30 min. Subsequently, the 
pellet was used for the isolation of plasmid-DNA according to the Maxiprep Kit protocol. 
 
3.2.2.2 RNA isolation, reverse transcription and real-time PCR 
Cells were washed with PBS and scraped in extraction buffer (peqGOLD TriFast, Peqlab 
Biotechnology GmbH, Erlangen, Germany). RNA isolation was performed in accordance 
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with the manufacturer’s instruction. To eliminate potential DNA contamination, RNA 
(1μg) was mixed with H2O and 1μl of DNAse (1U/μl) to a final volume of 20µl and 
incubated for 30 min at 37°C and 7 min at 75°C. After cooling on ice, the following 
components were added to each sample: 8μl of M-MuLV reaction buffer (5x), 4μl of 
deoxynucleotide triphosphate mixture (10mM of each nucleotide), 2μl of random 
hexamer primer (100μM), 2μl of H2O, 2μl of RiboLock RNAse inhibitor (40U/μl), 2μl of 
ReverseAid M-MuLV reverse transcriptase (20U/µl) (all from Fermentas Life Sciences, 
Burlington, Ontario, Canada). After 60 min at 39°C, the reverse transcriptase was 
inactivated by heating the mixture at 96°C for 2 min. As a negative control, reverse 
transcriptase was omitted from the reactions. The cDNA was used as a template in the 
real-time PCR reactions using the primer pairs listed in section 2.1.5. The real-time PCR 
was performed using the ABI Prism 7300 Detection System (Applied Biosystems, 
Lincoln Centre Drive Foster City, CA, USA) with SYBR-Green as fluorescent dye, 
enabling real-time detection of PCR products. The real-time PCR mixture was prepared 
according to the manufacturer’s protocol (Platinum SYBR Green qPCR SuperMix-UDG, 
Invitrogen, Carlsbad, CA, USA). Cycling conditions were 50°C for 2 min, 95°C for 10 
min, followed by 45 cycles of 94°C for 10 s, 55°C for 20 s, 72°C for 30 s. For 
quantification, the target gene was normalized to β-actin mRNA, using the standard 
equation for real-time PCR analysis: T0/R0=k2CT,R-CT,T with T0 representing the initial 
number of target gene mRNA copies, R0 representing the initial number of standard gene 
mRNA copies, CT,R is the threshold cycle of reference (β-actin) and CT,T threshold 
cycle of target gene. The values of the control groups were normalized to 1. 
 
 3.2.2.3 DNA agarose gel electrophoresis  
The DNA samples were mixed with loading buffer and loaded onto a 1% agarose gel. 
The electrophoresis was performed for around 1 hour with 5 V/cm. The negatively 
charged DNA migrated from the cathode (-) to the anode (+). To visualize DNA, the gel 
was treated with ethidium bromide that intercalates into the DNA double strands forming 
a fluorescent complex by excitation with UV light. DNA bands were detected by 
chemiluminiscence imager (FluorchemTM IS-8900). The size of DNA fragments was 
determined by comparison with a DNA size marker. 
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3.2.2.4 RNA interference by synthetic siRNA 
Selective inhibition of target gene was performed using specific siRNAs. As a control, a 
siRNA sequence (si-con) was employed that does not target any gene in the human 
genome and has been tested by micro-array analysis (Dharmacon Inc., Chicago, IL, 
USA). The forward (+) and reverse (-) strands of the siRNAs were synthesized 
commercially (Biomers.net GmbH, Ulm, Germany). Forward (+) and reverse (-) strands 
were annealed at a final concentration of 40mM each by incubation at 95oC for 1 min and 
at 37oC for 1 hour in annealing buffer (20mM K-acetate, 0.4mM Mg-acetate 6mM 
HEPES, pH=7.4). 
 
 3.2.2.5 Plasmids 
The full length NOX1 or NOX4 cDNA was ligated into the pCMV-HA plasmid. NOX1 
was tagged with HA at its N- or C-terminus and NOX4 at its C-terminus and their 
integrity was confirmed by sequencing. The Trx1 cDNA was ligated into pIRES vector. 
The Trx1 plasmid was kindly provided by Prof. Brüne (Frankfurt/Main) and it was 
described previously [196]. The pGL3-TK plasmid with the thymidine kinase minimal 
promoter was used to construct the HRE- and ARE-reporter plasmids as described [197]; 
[198]. The forward and reverse oligonucleotides of the HRE from the phosphoglycerate 
kinase (PGK) gene and the forward and reverse oligonucleotides from the NADPH 
quinone-oxido-reductase (NQO1) gene were employed for plasmid construction. The 
oligonucleotide sequences for the production of the relevant PCR products are given in 
section 2.1.6.  
 
3.2.3 Cell biological methods 
3.2.3.1 Cell culturing under different oxygenation conditions    
Cells were incubated at 37oC in a water-saturated atmosphere containing 5% CO2 in air 
(normoxic conditions). A hypoxic environment was prepared in a chamber equilibrated 
with a water-saturated gas mixture of 1% O2, 5% CO2 at 37oC (Innova CO-48, New 
Brunswick Scientific, Edison, NJ, USA). For culturing of cells in the different normoxic 
and hypoxic exposure intervals, cells were transferred between these two chambers. 
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When switching from normoxic to hypoxic conditions, the equilibration time to reach 1% 
O2 within the cell supernatant was determined as about 1 hour, and vice verse, within 
minutes.  
 
3.2.3.2 Cell transfection by siRNA and plasmid 
Transfection of cells with siRNA and plasmid was performed by Lipofectamine 2000 
according to the company’s protocol. The final concentration of siRNA was 100nM and 
the amount of plasmid used for transfection was approx. 2μg per 150000 cells. After 
transfection, cells were incubated with OPTI-MEM for six hours, then the OPTI-MEM 
was replaced by cell culture medium. Cells were grown for 48 hours after siRNA 
transfection and for 24 hours after plasmid transfection.             
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4. Results  
4.1 Detection of NOX1 and NOX4 proteins, and analysis of NOX1- and NOX4-
dependent ROS generation  
4.1.1 Expression of NOX1 and NOX4 mRNA in A549 cells 
Firstly, the presence of NOX1 and NOX4 mRNA in A549 cells was demonstrated using 
specific primers applied in RT-PCR (Figure 8A, B, upper panels). Secondly, the same set 
of primers was used for quantification of mRNA by real-time RT-PCR (Figure 8A, B, 
lower panels). Expression of NOX1 mRNA in A549 was compared to NOX1 expression 
in CaCo2 cells employed as a cell line with high abundance of NOX1. NOX4 mRNA 
expression in A549 cells was compared to NOX4 expression in HUVEC employed as a 
cells with high abundance of NOX4. In both cases, the number of mRNAs copies in 
A549 cells was normalized to 1. As expected, the quantification of mRNA by real-time 
RT-PCR revealed a significantly higher level of NOX1 mRNA in CaCo2 cells when 
compared to A549, and significantly higher NOX4 mRNA level in HUVEC in 
comparison to A549.  
Finally, based on these results, we also compared ΔCt values from real-time RT-PCR of 
NOX1 and NOX4 in A549 cells (Figure 8C). The comparison showed significantly 
higher expression of NOX1 mRNA than NOX4 in A549 cells.                 
 
 
  A                                                                       B 
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 Figure 8: Expression of NOX1 and NOX4 mRNA in A549 cells  
A) Upper panel: Ethidium bromide stained agarose gel electrophoresis of RT-PCR 
analysis of NOX1 mRNA expression in A549 and CaCo2 cells. cDNA made from total 
RNA in the presence (+) or absence (-) of reverse transcriptase. Lower panel: 
Quantification of NOX1 mRNA levels by real-time RT-PCR in A549 and CaCo2 cells 
(** p<0.01, n=3, unpaired t-test). B) Upper panel: Ethidium bromide stained agarose gel 
electrophoresis of RT-PCR analysis of NOX4 mRNA expression in A549 cells and 
HUVEC. cDNA made from total RNA in the presence (+) or absence (-) of reverse 
transcriptase. Lower panel: Quantification of NOX4 mRNA levels by real-time RT-PCR 
in A549 cells and HUVEC (** p<0.01, n=3, unpaired t-test). C) Comparison of ΔCt 
values from real-time RT-PCR of NOX1 and NOX4 mRNAs in A549 cells (** p<0.01, 
n=4, unpaired t-test). In all experiments, β-actin was used as reference gene. 
 
4.1.2 Schema of binding sites of different NOX1 and NOX4 antibodies to NOX1 and 
NOX4 proteins  
The immunodetection of NOX1 and NOX4 proteins is a common problem since different 
antibodies display different patterns of immunoreactive protein bands in Western blot. 
Based on this fact, one of the aims of our work was to characterize and select the most 
suitable antibodies for NOX1 and NOX4 proteins detection. We used several 
commercially available and custom made antibodies targeted to different epitopes of 
NOX1 and NOX4 proteins. The schematic structure of NOX1 and NOX4 proteins with 
the binding sites of the different antibodies are depicted on Figures 9A and B.  
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Figure 9: Binding sites of NOX1 and NOX4 antibodies 
NOX1 and NOX4 antibodies binding sites, molecular weights, N- and C-terminus, length 
and characteristic domains of NOX1 and NOX4 proteins are depicted.  
 
4.1.3 Detection of putative NOX1 and NOX4 proteins by different antibodies in total 
cell lysates  
4.1.3.1 NOX1 antibodies (A549 versus CaCo2)  
Initially, western blot analyses of total cell lysates from A549 and CaCo2 cells were 
performed. For detection, five different NOX1 polyclonal antibodies were used. In 
addition, the mAb54.1 monoclonal antibody detecting primary NOX2 was applied since 
this antibody has been described to be able to recognize a fragment of NOX1 
recombinant protein [199]. 50ug of protein was loaded per well and β-actin was used as a 
loading control (Figure 10A).                   
The NOX1jh antibody produced by a custom service detected a band at 95kDa that was 
more strongly abundant in A549 than in CaCo2 cells. MOX1 H-75 detected the strongest 
bands at 45kDa and 50kDa. Both these proteins were present at a higher level in A549 
than in CaCo2 cells. MOX1 H-15 did not show any band. NOX1ab55831 showed bands 
at 38kDa, 60kDa and 80kDa. The 60kDa band was pronounced in A549 cells whereas the 
80kDa band in CaCo2 cells. NOX1wch detected two bands - the first at 55kDa and the 
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second at 65kDa. Both bands were more strongly abundant in CaCo2 than in A549 cells. 
mAb54.1 displayed a strong band at 55kDa with similar intensity in A549 and CaCo2 
cells. 
 
4.1.3.2 NOX4 antibodies (A549 versus HUVEC) 
At least three different polyclonal antibodies were used for detection of NOX4 in total 
cell lysate of A549 cells and HUVEC. Again, 50ug of protein was loaded per each well 
and β-actin was used as loading control (Figure 10B). 
The NOX4jh antibody (produced by a custom service) detected bands at 42kDa, 62kDa 
and at 67kDa in A549 cells and at 40kDa, 42kDa, 50kDa, 67kDa, 80kDa and 98kDa in 
HUVEC. The predicted size of NOX4 is 67kDa. The band of 67kDa was detected in both 
cell types but it was more strongly abundant in HUVEC than in A549 cells. On the other 
hand, proteins at 62kDa and 42kDa were very weakly expessed in HUVEC and strongly 
expressed in A549 cells. Bands at 40kDa, 50kDa, 80kDa and 98kDa were only present in 
HUVEC and not in A549. NOX4 H-300 and NOX4 N-15 did not detect any bands. 
 
A                                                                                               B 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Detection of putative NOX1 and NOX4 proteins in total cell lysates 
employing different NOX1 and NOX4 antibodies  
Western blot analysis of total cell lysates from A) A549 and CaCo2 cells employing 
different NOX1 antibodies, and from B) A549 cells and HUVEC employing different 
NOX4 antibodies. 50μg of protein were loaded per well and β-actin was used as loading 
control.  
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4.1.4 Detection of putative NOX1 and NOX4 proteins, p22phox and NOXO1 in cell 
compartments                                                                                                            
4.1.4.1 NOX1  in cytosol, membrane, nuclei and cytoskeleton 
NOX1 has been described as a 50-65kDa protein anchored in the plasma membrane. 
Thus in the next step, we were interested in the subcellular localization of proteins 
reacting with different NOX1 antibodies. Since the antibodies were not suitable for 
immunocyto-staining, we performed subcellular fractionation. Cytosolic, membrane, 
nuclear and cytoskeleton fractions were separated using the Complete Cell Fraction Kit. 
The purity of crude fractions was evaluated by relevant cellular markers (Figure 11D). 
Again, five NOX1 antibodies and mAb54.1 were used to detect potential NOX1 proteins 
(Figure 11A). 
NOX1jh detected a band at 95kDa localized most strongly in the cytosol and less strongly 
in the membrane and nuclei of A549 cells. In CaCo2 cells, this band was expressed 
almost equally in cytosol, membrane and nuclei. In both A549 and CaCo2 cells, MOX1 
H-75 detected bands at 43kDa in the membrane and nuclei, a very weak 50kDa band and, 
a 55kDa band in the nuclei and two bands between 72 and 95kDa also in the nuclei. 
MOX1 H-15 visualized bands at 67kDa, 80kDa and 97kDa in the nuclei, both in A549 
and CaCo2 cells beside weak 60kDa and 45kDa bands in the cytosol of A549 cells. 
NOX1ab55831 interacted with a protein band at 60kDa mainly in the cytosol. This band 
was stronger in A549 than in CaCo2 cells. Additional bands at 40kDa and 90kDa both in 
A549 and CaCo2 cells were detected. NOX1wch displayed strong band at 55kDa and a 
weaker band at 65kDa, both bands were localized predominantly in the cytoskeleton and 
at a lower level in the nuclei. An additional weak 67kDa band was present in the 
cytoskeleton fraction of CaCo2 cells. The 55kDa and 65kDa bands were slightly more 
abundant in CaCo2 than in A549 cells. Other strong immunoreactive proteins were 
detected with the NOX1wch antibody at the position of 43kDa in all fractions. 
Interestingly, this antibody also detected a band at 97kDa (more strongly in CaCo2 than 
in A549 cells) in nuclei that seemed to be in common with the band detected by MOX1 
H-15 in the same fraction. mAb54.1 detected a band at 55kDa in the cytosol, membrane, 
and nuclei both in A549 and in CaCo2 cells, a 70kDa band in the membrane of A549 and 
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a 60kDa band in the cytosol of CaCo2 cells. Additionally, several weak bands were 
present in CaCo2 cells in the range of 60-72kDa in the membrane, nuclei and cytosol.           
 
4.1.4.2 NOX4  in cytosol, membrane, nuclei and cytoskeleton 
Subcellular fractionation was also performed for the detection of NOX4 proteins (Figure 
11B). 
NOX4jh detected a strong band at 62kDa predominantly in the cytosol and a 67kDa band 
predominantly in the cytoskeleton of A549 cells. The band of 62kDa was almost not 
present in HUVEC and the band of 67kDa was most strongly present in nuclei and 
weakly in the cytoskeleton of HUVEC. Additional bands at 80kDa observed only in the 
cytosol and at 50kDa in the cytosol and cytoskeleton were detected in HUVEC. NOX4 
H-300 reacted with a band of 65kDa that was highly abundant in the cytosol and weakly 
in the membrane of A549 cells. Additional weak bands at 67kDa in the membrane and at 
72kDa in the cytosol of A549 cells also reacted with this antibody. In HUVEC, the 
NOX4 H-300 only detected a very weak band at 72kDa in the cytosol. NOX4 N-15 did 
not detect any band.               
 
4.1.4.3 p22phox and NOXO1  in cytosol, membrane, nuclei and cytoskeleton 
p22phox and NOXO1 have been described as essential components of the functional 
NADPH oxidase complex containing NOX1. Thus, in the context to the previous 
experiments demonstrating different localizations of potential NOX1 proteins, we were 
interested, in which fractions these two subunits would be localized. Both in A549 and 
CaCo2 cells, p22phox was most highly abundant in the membrane, less in nuclei and a 
very low abundance was observed in the cytoskeleton. In the cytosolic fraction, p22phox 
was almost undetectable. Interestingly, NOXO1 was almost entirely present in the 
cytoskeleton fraction of A549 and CaCo2 cells (Figure 11C). 
In order to evaluate the purity of the subcellular fractions, different cellular compartment 
markers were applied. PGK1/2 was used as a typical cytosolic protein, Na+/K+-ATPase α 
as a (plasma) membrane protein, cytokeratin (types 5, 6, 8, 17) as a cytoskeleton proteins 
and lamin B as a nuclear and cytoskeleton protein. As displayed in Figure 11D, the 
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subcellular fractionation showed only small cross-contamination by the appropriate 
markers. In this regard, interesting observations were that these types of cytokeratin were 
not detectable in HUVEC and that lamin B was mainly localized in the cytoskeleton of 
A549 and CaCo2 cells, but in nuclei and cytoskeleton of HUVEC. Lamin B is a 
component of nuclear intermediate filaments that are known to be difficult to dissolve in 
many weak detergents, including likely those employed for the cell lysis in our study. 
Therefore, this observation may be explained by differences of the solubility of lamin B 
complexes that may be altered between different cell types.  
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Figure 11: Detection of putative NOX1 and NOX4 proteins, p22phox and NOXO1 in 
different cell compartments  
Western blot analysis of subcellular fractions (cytosol (C), membrane (Me), nuclei (Nu) 
and cytoskeleton (Csk) from A) A549 and CaCo2 cells using different NOX1 antibodies, 
B) A549 cells and HUVEC using different NOX4 antibodies, C) A549 and CaCo2 cells 
using p22phox and NOXO1 antibodies, D) A549, CaCo2 cells and HUVEC using 
antibodies against different subcellular markers (PGK1/2 - cytosol marker, Na+/K+-
ATPase α – membrane marker, cytokeratin – cytoskeleton marker, lamin B – 
cytoskeleton and nucleus marker). In experiments A, B, C 50μg of protein and in D 20μg 
of protein were loaded per well.  
 
4.1.5 Detection of putative NOX1 and NOX4 proteins, p22phox and NOXO1 in Tx-
100 soluble and insoluble fraction 
Non-ionic detergents such as Triton X-100 (Tx-100) are commonly used for 
permeabilization of cell membranes. Another technical approach employing Tx-100 is 
centrifugal separation of the Tx-100 soluble fraction containing cytosolic, organelle and 
membrane proteins and of the Tx-100 insoluble fraction containing cytoskeleton and 
cytoskeleton associated proteins. Since the previous experiment applying the Complete 
Cell Fractionation Kit showed that some of NOX1 and NOX4 immunoreactive proteins 
were localized in the cytoskeleton fraction, we wanted to know whether the use of Tx-
100 would confirm these results.     
 
4.1.5.1 NOX1  in Tx-100 soluble and insoluble fraction 
The NOX1jh antibody detected a band at 95kDa that was localized both in the 14000g 
pellet (p) and in the supernatant (s) in samples not treated with Tx-100. In contrast, in 
samples treated with Tx-100 this protein was localized predominantly in the 14000g 
supernatant representing the Tx-100 soluble fraction. This phenomenon was observed 
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both in A549 and CaCo2 cells. The MOX1 H-75 immunoreactive band at 43kDa was 
mainly localized in the supernatant after 14000g centrifugation both in samples with and 
without Tx-100. Additionally, several weak bands occurred in the 14000g pellets, both in 
A549 and CaCo2 cells. MOX1 H-15 did not detect any band. NOX1ab55831 displayed a 
band at 60kDa in A549 but not in CaCo2 cells. This band was present in the 14000g 
supernatant regardless of treatment by Tx-100. NOX1wch detected bands at 55kDa and 
65kDa that were always enriched in the 14000g pellet. After treatment of the samples 
with Tx-100, the abundance of the 55kDa band in the Tx-100 soluble fraction of CaCo2 
was increased (Figure 12A).     
 
4.1.5.2 NOX4  in Tx-100 soluble and insoluble fraction 
The NOX4jh antibody detected bands at 62kDa and 67kDa in A549 cells. The 62kDa 
band was mainly present in the 14000g supernatant and the 67kDa band in the 14000g 
pellet both in samples with and without Tx-100. In HUVEC, bands at 50kDa, 67kDa and 
80kDa were detected. Without addition of Tx-100, the 80kDa band was present in the 
14000g supernatant whereas the 50kDa and 67kDa bands were strongly present in the 
pellet and weakly in the supernatant. Treatment of samples with Tx-100 slightly 
increased the presence of 50kDa and 67kDa proteins in the 14000g supernatant. NOX4 
H-300 detected only a pronounced band in HUVEC at the position of 42kDa in the 
14000g supernatant. NOX4 N-15 did not detect any band (Figure 12B).        
 
4.1.5.3 p22phox and NOXO1 in Tx-100 soluble and insoluble fraction 
p22phox was present at a similar level in the 14000g supernatant and the pellet in 
samples not treated with Tx-100. After treatment of the cell lysates with Tx-100, 
p22phox was much stronger abundant in the 14000g supernatant (Figure 12C). This was 
a typical observation both for A549 and CaCo2 cells.  
NOXO1 was localized in the 14000g pellet, but after adding Tx-100 it was partially 
transferred to the Tx-100 soluble fraction in A549 cells and completely transferred to this 
fraction in CaCo2 cells (Figure 12C). Interestingly, the NOXO1 antibody showed a 
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double band in A549 cells but a single band in CaCo2 cells. The double band may 
represent different splice variants or phosphorylation states of NOXO1.  
The effects of Tx-100 on the solubility of membrane and cytoskeleton associated 
proteins, were evaluated with the different subcellular compartments markers (Figure 
12D). PGK1/2 used as the cytosolic marker was always present in the 14000g supernatant 
without regard to Tx-100 treatment. Similarly, the intermediate filament component 
cytokeratin was always present in the 14000g pellet. On the other hand, the plasma 
membrane marker Na+/K+-ATPse α was present both in the 14000g pellet and in the 
supernatant of samples containing no Tx-100. However, addition of Tx-100 caused a 
transfer of this membrane protein to the Tx-100 soluble fraction indicating that Tx-100 
effectively solubilized membrane proteins. As observed previously, the particular types 
of cytokeratins were not detectable in HUVEC.  
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Figure 12: Detection of putative NOX1 and NOX4 proteins, p22phox and NOXO1 in 
Tx-100 soluble and insoluble fractions 
Western blot analysis of cell lysates fractionated by centrifugation after treatment with 
Tx-100 (+) or without treatment (-) from A) A549 and CaCo2 cells employing different 
NOX1 antibodies, B) A549 cells and HUVEC employing different NOX4 antibodies,   
C) A549 and CaCo2 cells employing p22phox and NOXO1 antibodies, D) A549, CaCo2 
cells and HUVEC employing antibodies against different subcellular markers. In A, B, C 
experiments 50μg of protein and in D 20μg of protein per well were loaded. 
 
4.1.6 Detection of putative NOX1, NOX4 proteins and p22phox in the plasma 
membrane of A549 cells 
Both NOX1 and NOX4 have been suggested to be plasma membrane proteins. However, 
our results applying different NOX1 and NOX4 antibodies for the analysis of subcellular 
fractions did not confirm the membrane localization of these proteins. In order to ensure 
that the potential NOX1 and NOX4 proteins were not localized in the plasma membrane, 
we performed Western blot analysis of proteins from high purity plasma membrane 
fraction. Accurate and selective plasma membrane isolation was achieved by using a 
commercially available Membrane Isolation Kit. Western blots were performed with the 
NOX1 and NOX4 antibodies that appeared to have the best immunoreactive properties. 
NOX1jh detected a band at 95kDa that was present in all fractions. NOX1ab55831 
detected bands at 60kDa in the cytosol, at 95kDa predominantly localized in the cytosol 
and at 43kDa present in all fractions. NOX1wch detected 55kDa and 65kDa bands in the 
total membrane fraction containing however also cytoskeleton proteins and a 43kDa band 
in all fractions. NOX4jh detected a 67kDa band localized mainly in the total membrane 
fraction and a 62kDa band localized in the cytosolic fraction. In addition, a weak 80kDa 
band was detected in the plasma membrane fraction (Figure 13A).   
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Interestingly, p22phox was most strongly abundant in the total membrane fraction and 
very weakly in the plasma membrane fraction. There was no p22phox signal in the 
cytosolic fraction (Figure 13B). 
For evaluation of the separation processes, the markers of the cytosol (PGK1/2), 
cytoskeleton (cytokeratin) and plasma membrane (Na+/K+-ATPse α) were used. Indeed, 
as demonstrated at Figure 13C, PGK1/2 was mainly present in the cytosol, cytokeratin in 
the total membrane fraction containing also cytoskeletal proteins, and Na+/K+-ATPse α 
was most strongly abundant in the plasma membrane fraction and less in total membrane 
fraction. 
 
    A 
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Figure 13: Detection of putative NOX1, NOX4 proteins and p22phox in plasma 
membrane of A549 cells 
Western blot analysis of cytosolic (C), total membrane (T.Me.) and plasma membrane 
(Pl.Me.) fractions from A549 cells employing A) NOX1 and NOX4 antibodies,             
B) p22phox antibody, C) antibodies against different subcellular markers. In A, B 
experiments 50μg of protein and in C 20μg of protein per well were loaded.  
 
4.1.7 Knock-down of NOX1 and NOX4 in A549 cells by siRNA  
In parallel with applying different antibodies and subcellular fractionation, knock-down 
of NOX1 and NOX4 by siRNA was used as another approach for identification of NOX1 
and NOX4 proteins. We have designed several siRNAs targeting different sequences of 
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NOX1 and NOX4 genes. Subsequently, we selected the most effective siRNAs based on 
NOX1- and NOX4-mRNA quantification by real-time RT-PCR (Figure 14A, B upper 
panels). Transfection of A549 cells by these siRNAs and subsequent incubation for 48 
hours considerably decreased the mRNA levels of NOX1 and NOX4. Next, we tested the 
effect of siRNA treatment on immunoreactive NOX1 and NOX4 antibodies proteins. Si-
NOX1 decreased the level of the 55kDa and 65kDa bands detected by NOX1wch. Bands 
detected by NOX1jh and NOX1ab55831 were not decreased (Figure 14A, lower panels) 
employing the si-NOX1. Si-NOX4 effectively down-regulated a band at 67kDa but not at 
62kDa (Figure 14B, lower panels).                 
       A                                                                         B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: Knock-down of NOX1 and NOX4 in A549 cells by siRNA 
A) Upper panel: Quantification of NOX1 mRNA level by real-time RT-PCR in A549 
cells transfected with si-con or si-NOX1 (** p<0.01, n=3, unpaired t-test). β-actin was 
used as reference gene. Lower panel: Western blot analysis of total cell lysates from 
A549 cells transfected with si-con or si-NOX1 employing different NOX1 antibodies. β-
actin was used as a loading control. B) Upper panel: Quantification of NOX4 mRNA 
level by real-time RT-PCR in A549 cells transfected with si-con or si-NOX4 (* p<0.05, 
n=3, unpaired t-test). β-actin was used as reference gene. Lower panel: Western blot 
analysis of total cell lysate from A549 cells transfected with si-con or si-NOX4 
employing NOX4jh antibody. β-actin was used as loading control. For all Western blot 
analyses, 50μg of protein were loaded per well. 
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4.1.8 Interaction of NOX1wch and NOX4jh antibodies with recombinant NOX1 and 
NOX4 proteins 
Using the siRNA approach in the previous experiments, NOX1wch and NOX4jh were 
determined as the most suitable antibodies for the detection of endogenous NOX1 and 
NOX4 protein in A549 cells. Both NOX1 and NOX4 were present in the Tx-100 
insoluble fraction, representing likely mainly cytoskeleton and cytoskeleton associated 
proteins. Based on these results, we further investigated whether firstly, NOX1wch and 
NOX4jh are also able to recognize recombinant NOX1 and NOX4 proteins and, 
secondly, whether recombinant NOX1 and NOX4 would also be localized in the Tx-100 
insoluble fraction.  
A549 cells were transiently transfected with HA-tagged NOX1- and HA-tagged NOX4-
encoding plasmids (NOX1-HA, NOX4-HA). 24 hours after transfection, cells were lysed 
in Tx-100 containig buffer and Tx-100 soluble and insoluble fractions were separated and 
subjected to Western blot.  
NOX1wch detected bands at 55kDa and 65kDa in the Tx-100 insoluble fraction of 
NOX1-HA transfected and non-transfected cells. In addition, a band at 46kDa appeared 
only in transfected cells (Figure 15A). When using a monoclonal HA antibody for 
analysis of these samples, bands at 55kDa and 46kDa in the Tx-100 insoluble fraction of 
NOX1-HA transfected cells and no band in non-transfected cells were detected (Figure 
15A). The 46kDa protein band that was detected both with NOX1wch and HA-antibody 
may be a proteolytic cleavage product of highly expressed NOX1-HA. 
NOX4jh detected several weak bands in the range of 62kDa and a strong band at 40kDa 
in the Tx-100 insoluble fraction, only in NOX4-HA transfected cells, but not in non-
transfected cells. The endogenous 62kDa and 67kDa bands detected with NOX4jh were 
common for transfected and non-transfected cells (Figure 15B). The HA-antibody 
visualized a strong double band in the range of 62kDa and a weak band at 40kDa in the 
Tx-100 insoluble fraction of transfected but not in non-transfected cells (Figure 15B). 
Using the same antibodies, proteins from total cell lysate of A549 cells transfected with a 
plasmid encoding NOX4E-HA (a truncated NOX4 splice variant) were analysed by 
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Western blot. Both NOX4jh and HA antibodies displayed strong immunoreactivity with 
NOX4E-HA (Figure 15B, right panel). 
 
  A 
 
 
 
 
 
 
 
 
 
   
 B 
 
 
 
 
 
 
 
 
 
Figure 15: Interaction of NOX1wch and NOX4jh antibodies with recombinant 
NOX1 and NOX4 proteins 
A) Western blot analysis of Tx-100 soluble and insoluble fractions from A549 cells 
transfected with empty plasmid or with NOX1-HA plasmid employing NOX1wch- or 
HA-antibody. B) Left panel: Western blot analysis of Tx-100 soluble and insoluble 
fractions from A549 cells transfected with empty plasmid or with tagged NOX4-HA 
plasmid employing NOX4jh- or HA-antibody. Right panel: Western blot analysis of total 
cell lysate from A549 cells transfected with empty plasmid or with NOX4E-HA plasmid 
employing NOX4jh- or HA-antibody. In all experiments, 30μg of protein were loaded per 
well. 
 
4.1.9 Localization of NOX1, NOX4, p22phox and NOXO1 in cell nuclei 
The experiment applying siRNA for inhibition of NOX1 and NOX4 revealed NOX1wch 
and NOX4jh as most suitable antibodies for the detection of these proteins. Both NOX1 
and NOX4 proteins were demonstrated to be associated with the cytoskeleton. The 
cytoskeleton is also part of the nuclei. Furthermore, NOX4 and other NOXs have been 
detected in nuclei of several cell types. Thus, in the next step, we were interested whether 
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NOX1 and NOX4 are localized in the nuclei of A549 and CaCo2 cells or HUVEC. For 
isolation of high purity nuclear fraction we used Nuclear and Cytoplasmic Extraction 
Reagents kit.  
NOX1wch detected bands at 55kDa and 65kDa that both were more abundant in CaCo2 
in comparison to A549 cells. In CaCo2 cells, both bands were strongly localized in the 
nuclear insoluble fraction containing cytoskeletal proteins and weakly in nuclear soluble 
fraction containing soluble proteins from the nuclear lumen and nuclear membrane. In 
contrast, the 55kDa protein in A549 cells was present only in the nuclear soluble fraction 
whereas the 65kDa band was predominantly present in the nuclear insoluble fraction 
(Figure 16A).  
NOX4jh visualized a strong band at 62kDa mainly localized in the cytosolic fraction 
(containing also membrane proteins) and a 67kDa band mainly localized in the nuclear 
insoluble fraction of A549 cells. The same antibody showed a strong band at 67kDa both 
in the nuclear soluble and the insoluble fraction and at 50kDa and 40kDa in the nuclear 
insoluble fraction of HUVEC (Figure 16B). 
p22phox was present strongly in the cytosolic fraction, in the nuclear soluble fraction and 
weakly in the nuclear insoluble fraction of A549 and CaCo2. NOXO1 was present only 
in the nuclear insoluble fraction of both these cell types (Figure 16C). 
Lamin B is a typical nuclear protein, thus we used it as nuclear marker. Lamin B is also 
part of intermediate filaments. In accordance with this, lamin B was present strongly both 
in the nuclear soluble and insoluble fractions but not in the cytosolic fraction (Figure 
16A, B).                                 
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Figure 16: Localization of NOX1, NOX4, p22phox and NOXO1 in cell nuclei 
Western blot analysis of cytosolic (C), nuclear soluble (NuSol) and nuclear insoluble 
(NuIns) fractions from A) A549 and CaCo2 cells employing NOX1wch and lamin B 
antibodies, B) A549 cells and HUVEC employing NOX4jh and lamin B antibodies,      
C) A549 and CaCo2 cells employing p22phox and NOXO1 antibodies. In all 
experiments, 40μg of protein were loaded per well. 
 
4.1.10 Regulation of NOX1 and NOX4 stability by p22phox 
One of the important roles of p22phox is stabilization of NOX proteins during their 
synthesis in the ER. In fact, p22phox is suggested to form a heterodimer with NOX 
proteins and thereby protecting NOX from proteasomal degradation. Based on this 
observation, we were interested whether p22phox inhibition would influence the stability 
of NOX1 and NOX4. We did not observe any effect of p22phox inhibition on the 
endogenous NOX1 and NOX4 protein levels (Figure 17A). Furthermore, we 
overexpressed recombinant NOX1-HA and NOX4-HA in cells treated with si-p22phox 
(24h prior to transfection with plasmid). p22phox inhibition led to a strong decrease of 
the abundance of recombinant NOX1 and NOX4 proteins (Figure 17B). To test whether 
the effect of p22phox knock-down on NOX1 and NOX4 proteins was mediated by 
proteosomal degradation, we treated cells by MG132, a proteasomal inhibitor. Indeed, 
MG132 treatment partially canceled the down-regulatory effect of si-p22phox on 
recombinant NOX1 and NOX4 proteins (Figure 17C).         
Furthermore, we also investigated the effect of the inhibition of NOX1 and NOX4 on the 
p22phox protein expression. Interestingly, whereas knock-down of NOX1 decreased the 
level of endogenous p22phox, knock-down of NOX4 showed no strong effect on the 
p22phox protein level (Figure 17D, upper panels). The inhibition of p22phox by siRNA 
was also validated (Figure 17D, lower panel).      
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Figure 17: Regulation of NOX1 and NOX4 stability by p22phox 
A) Western blot analysis of total cell lysates from A549 cells transfected with si-con or 
si-p22phox employing NOX1wch and NOX4jh antibodies. B) Western blot analysis of 
total cell lysates from A549 cells transfected with si-con or si-p22phox and NOX1-HA or 
NOX4-HA plasmid employing HA antibody. C) Western blot analysis of total cell 
lysates from A549 cells transfected with si-con or si-p22phox and with NOX1-HA or 
NOX4-HA plasmid and treated by solvent (DMSO) or MG132 employing HA antibody. 
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D) Upper panel: Western blot analysis of total cell lysates from A549 cells transfected 
with si-con or si-NOX1 or si-NOX4 employing p22phox antibody. Lower panel: Western 
blot analysis of total cell lysate from A549 cells transfected with si-con or si-p22phox 
employing p22phox antibody. In all experiments, 40μg of protein were loaded per well 
and detection of β-actin was performed to control protein loading.  
 
4.1.11 Purification of putative NOX1 and NOX4 proteins 
In parallel with the developing of effective siRNAs to knock-down NOX1 and NOX4 
proteins employed for the evaluation of the different antibodies, we also attempted to 
purify some of the potential NOX1 and NOX4 proteins. NOX1wch that subsequently 
turned out to be the most suitable antibody for the detection of NOX1, visualized strong 
band at 55kDa and weak band at 65kDa (both in A549 and in CaCo2 cells). Similarly, 
NOX4jh detected bands at 67kDa and 62kDa in A549 cells, and in addition a strong band 
at 50kDa and previously described 80kDa band in HUVEC. However, the theoretically 
predicted size of NOX1 is 65kDa and of NOX4 67kDa. In addition, several splice 
variants of NOX4 and NOX1 have been found at the mRNA level. In the context of all 
these observations and facts, we aimed at the identification of some putative NOX1 and 
NOX4 immunoreactive proteins.      
 
4.1.11.1 Strategy of purification 
Since subcellular fractionation and subsequent cutting of relevant bands areas directly 
from polyacryl-amid gel or PVDF membrane appeared not to suitable for the detection of 
low abundant proteins by MALDI-TOF MS or N-terminal sequencing, we attempted to 
perform gradual protein purification to get high amount and purity of potential NOX1 
and NOX4 proteins. The purification procedure consisted of several steps, primary based 
on HPLC protein purification as depicted on Figure 18. After each purification step an 
aliquot of the purified fractions was used for Western blot analysis. The fraction 
containing the protein(s) of interest, was submitted to a further step of purification. 
Techniques like 2D gel electrophoresis (2D-GE) and MALDI-TOF MS (including 
preparation of samples for MS) were performed in cooperation with experienced staff at 
the Department of proteomics, Institute of Biochemistry, Giessen (Laboratory of Dr. G. 
Lochnit). 
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Finally, MALDI-TOF MS analysis of the purified putative NOX1 and NOX4 protein 
bands did not identify any protein as NOX-related protein. However, this does not 
exclude that some of these bands may represent NOX1 or NOX4 proteins. The most 
critical factors of the performed purification processes are discussed in chapter 5.1.4.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: Schema of purification strategy for the identification of putative NOX1 
and NOX4 proteins 
Main purification steps are labeled by thick arrows and alternative ways of purification 
are labeled by thin, dashed arrows 
 
4.1.11.2 Homogenization and fractionation 
A549 cells were homogenized and fractionated by gradual centrifugation according to the 
protocol described in the Method section.  
MOX1H-15 and NOX1wch were used for the detection of NOX1 in A549 cells because, 
firstly, these antibodies were reacting with protein bands near to the predicted size of 
NOX1 and, secondly, both antibodies were described previously as relevant for NOX1 
detection [21], [200], [201], [18], [29], [14]. MOX1H-15 detected bands at 60kDa and 
45kDa in 110000g supernatant, whereas NOX1wch detected bands at 55kDa in 1050g 
and 14000g pellet, 65kDa in 14000g pellet and 45kDa in 110000g supernatant and in 
1050g, 14000g pellet (Figure 19, left panels). NOX4jh was used for detection of NOX4 
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proteins in HUVEC (Figure 19, right panels). This antibody detected bands at 62kDa and 
67kDa in 1050g fraction, and 62kDa and 80kDa bands in 110000g supernatant. In 
addition, mAb54.1 and p22phox antibodies were used for analysis of these fractions 
(Figure 19, right panels). mAb54.1 detected a band at 50kDa in all fractions, at 70kDa a 
double band in all fractions except 110000g supernatant, and a very weak band at 90kDa 
in the 1050g pellet fraction. The p22phox antibody detected a band at 22kDa most 
strongly in 1050g and less in 14000g and 110000g pellets. In the 110000g supernatant, 
there was no p22phox immunoreactive band.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: Homogenization and fractionation of A549 cells and HUVEC 
Western blot analysis of lysates from A549 cells or HUVEC after mechanic 
homogenization (using Dounce homogenizer) and centrifugal fractionation employing 
NOX1 (MOX1 H-15, NOX1wch) (left panels), NOX4jh, mAb54.1 and p22phox (right 
panels) antibodies. In all experiments, 40μg of protein per well were loaded.       
 
4.1.11.3 Chromatographic or 2D gel electrophoretic protein purification for 
MALDI-TOF MS  
After homogenization and centrifugal separation, the relevant fractions were dissolved or 
diluted in the appropriate buffer and used for further purification (Figures 20A-H).  
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A1) The 110000g supernatant (from A549) containing 60kDa and 45kDa MOX1H-15 
immunoreactive bands was subjected to anion exchange chromatography (AEC). The 
fractions were analysed by Western blot. A 60kDa band was detected in the fractions 15 
and 16, and a 45kDa band was present mainly in the fraction 16. The fractions 15 and 16 
were pooled together and further analysed by reverse phase chromatography (RPC). RPC 
fractions were submitted to Western blot. A 60kDa band was present in the fractions 36 
and 37, and a 45kDa band was predominantly in fraction 43. The selected fractions 
(36,37 and 43) were again loaded on gel that was stained by Coomassie blue. The bands 
visible at the corresponding molecular weight were cut for MALDI-TOF MS analysis. 
The 60kDa band was identified as pyruvate kinase isozymes M1/M2 and the 45kDa as β-
actin. 
Figure 20A-H: Purification of proteins by chromatography or 2D gel electrophoresis 
for further analysis by MALDI-TOF MS 
   
 A1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20A1: The supernatant from A549 cells after centrifugation at 110000g subjected 
to HPLC purification: Upper panel: Western blot analysis of different fractions and the 
flow-through (FT) from anion exchange chromatography (AEC) employing MOX1 H-15 
antibody. The bands of interest, numbers of individual fractions and the gradient of NaCl 
are presented. Lower panel: Western blot analysis of fractions 15 and 16 from AEC 
subjected to reverse phase chromatography (RPC) employing MOX1 H-15 antibody for 
detection. Bands of interest, numbers of individual fractions and the acetonitrile (ACN) 
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gradient are labeled. 60kDa and 45kDa proteins from the positive fractions (36, 37 and 
43) were subsequently analysed by MALDI-TOF MS. 
 
A2) Each HPLC purification run was recorded in a chromatogram. Figure 20A2 is 
representing an example of the chromatograms, here particularly related to the 
purification of MOX1 H-15 immunoreactive proteins (60kDa and 45kDa). The upper 
panel is showing a chromatogram from AEC of the 110000g supernatant of A549 cells. 
The NaCl gradient, the buffer system, the column and the detection wavelength are given. 
The fractions were collected each minute. The lower panel is showing a RPC 
chromatogram of the fractions 15 and 16 from the AEC. The acetonitrile (ACN) gradient, 
the buffer system, column and the detection wavelength are given. The fractions were 
collected each minute (1fraction ≈ 1minute). Proteins of 60kDa and 45kDa from the RPC 
fraction 36, 37 and 43 were selected for MALDI-TOF MS analysis. 
    A2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20A2: AEC and RPC chromatograms from purification of MOX1 H-15 antibody 
immunoreactive proteins contained in the 110000g supernatant from A549 cells: Upper 
panel: AEC chromatogram. The NaCl gradient is represented by a dashed line in the 
chromatogram. Lower panel: RPC chromatogram. The ACN gradient is represented by a 
dashed line in the chromatogram. The buffer system, names of the columns and 
wavelengths for the detection of proteins in the eluates are described.  
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B) The 1050g and 14000g pellets (from A549cells) containing potential NOX1 bands at 
55kDa and 65kDa were dissolved in 6M urea, pooled together, filtered (DNA binding 
filter), mixed with AEC buffer A (1:5) and used for AEC. Both 55kDa and 65kDa 
NOX1wch immunoreactive bands were present in the flow-through (FT). Because of 
technical problems with RPC, the proteins in the AEC FT were precipited by acetone and 
directly used for 2D-GE. However, NOX1wch did not detected any prominent dots in the 
range of the molecular weight between 55kDa and 72kDa on the PVDF transferred from 
2D gel.   
    B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20B: 1050g and 14000g pellets (pooled together) from A549 cells subjected to 
AEC and 2D gel electrophoresis (2D-GE): Upper panel: Western blot analysis of 
fractions including the FT from AEC employing the NOX1wch antibody. Bands of 
interest, numbers of individual fractions and the NaCl gradient are labeled. Lower panel: 
Acetone precipitated proteins in FT were separated by 2D-GE, transferred to a PVDF 
membrane that subsequently was incubated with NOX1wch antibody. The pH gradient of 
the strip for isoelectric focusing (IEF) and the molecular weights are labeled. 
 
C) The 1050g pellet (from HUVEC) containing 67kDa and 62kDa NOX4 bands was 
dissolved in 6M urea, filtered (DNA binding filter), mixed with AEC buffer A (1:5) and 
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applied in AEC. NOX4jh detected bands at 69kDa and 66kDa in the FT, and a 62kDa 
protein most strongly present in fractions 13 and 14. The proteins in the FT were 
precipited by acetone and used for 2D-GE. In the range between 55kDa and 72kDa no 
strong dots on the corresponding PVDF membrane could be detected by NOX4jh. 
   C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20C: The 1050g pellet from HUVEC subjected to AEC and 2D-GE: Upper panel: 
Western blot analysis of fractions including the FT from AEC employing the NOX4jh 
antibody. Bands of interest, numbers of individual fractions and the NaCl gradient are 
labeled. Lower panel: Acetone precipitated proteins in FT were separated by 2D-gel 
electrophoresis, transferred to a PVDF membrane that subsequently was incubated with 
NOX4jh antibody. The pH gradient of the strip for IEF and the molecular weights are 
labeled. 
 
D) The 110000g supernatant (from HUVEC) containing a NOX4jh immunoreactive band 
at 80kDa was subjected to AEC. The 80kDa NOX4jh reactive band was present most 
strongly in fractions 20 and 21. These fractions were pooled together and applied for 
RPC. The band at 80kDa appeared in none of the RPC fractions. Thus the same AEC 
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fractions were also used for 2D gel electrophoresis. However, in the range of 72-95kDa 
not any strong dots were detected by NOX4jh. 
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Figure 20D: The 110000g supernatant from HUVEC subjected to AEC and RPC or 2D-
GE: Upper panel: Western blot analysis of fractions including the FT from AEC 
employing NOX4jh antibody. The bands of interest, numbers of individual fractions and 
NaCl gradient are labeled. Middle panel: Western blot analysis of the AEC fractions 20 
and 21 that were subjected to RPC. The ACN gradient in RPC is labeled. Lower panel: 
Acetone precipitated proteins in fractions 20 and 21 were separated by 2D-GE, 
transferred to a PVDF membrane that subsequently was incubated with NOX4jh 
antibody. The pH gradient of the strip for IEF and the molecular weights are labeled. 
 
E) The 1050g pellet from A549 cells containing a strong 70kDa and a weak 90kDa band 
immunoreacting with mAb54.1 was dissolved in 6M urea, filtered (DNA binding filter), 
mixed with AEC buffer A (1:5) and applied for AEC. The 70kDa band was in the FT and 
the 90kDa band was strongly present in fractions 14 and 15.  
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Figure 20E: The 1050g pellet from A549 cells subjected to AEC: Fractions including the 
FT from AEC were analysed by Western blot employing the mAb54.1 antibody. Bands 
of interest, numbers of individual fractions and the NaCl gradient are labeled. 
 
F) The 1050g pellet from A549 cells also contained the p22phox immunoreactive band. 
When this fraction was analysed by AEC, the p22phox band appeared in the FT. The FT 
was subsequently concentrated by ultrafiltration and used for preparative SDS-PAGE. 
Different protein amounts (25μg, 50μg, 75μg) were loaded on the gel. The p22phox 
antibody immunoreactive band was labeled on PVDF and cut for MALDI-TOF MS 
analysis. 50μg of protein was not sufficient for detection of any protein by MALDI-TOF, 
thus 75μg was used in the second round of analysis. A protein at 22kDa was surprisingly 
not identified as p22phox but as tetraubiquitin.                                           
  F 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20F: The 1050g pellet from A549 cells subjected to AEC and preparative SDS-
PAGE: Upper panel: Western blot analysis of fractions including the FT from AEC 
employing the p22phox antibody. Bands of interest, numbers of individual fractions and 
the NaCl gradient are labeled. Lower panel: Western blot analysis of acetone precipitated 
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proteins in FT employing the p22phox antibody. The amounts of proteins loaded per well 
are given. The p22phox-positive band (75μg of total protein) was subsequently analysed 
by MALDI-TOF MS.  
 
G) We also tried to analyse fractions from A549 cells after centrifugation of 1050g 
directly by RPC without preceding AEC. The 1050g pellet was dissolved in 6M urea, 
filtered by DNA binding filter, mixed with RPC buffer A (1:5) and applied in RPC. 
mAb54.1 detected a strong band at 70kDa in fractions 36, 37, 38, 39, and weak band at 
90kDa in fractions 35, 36 and 37. The fractions 36 and 37 were pooled together and 
loaded onto a preparative SDS-PAGE. In order to avoid cutting of non-matching bands 
from the gel, the whole area between 60-100kDa was cut into small pieces of gel slices 
that were subsequently submitted to MALDI-TOF MS analysis. However, none of the 
bands was identified as NOX2 or any other NOX protein. Examples of the identified 
proteins are given in the figure. 
  G 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20G: The 1050g pellet from A549 cells subjected to RPC: Western blot analysis 
of selected fractions from RPC employing m54.1 antibody. The whole gel area with 
bands of interest was subjected to MALDI-TOF MS analysis. The area containing the 
bands of interest, the numbers of individual fractions and the ACN gradient are labeled. 
Examples of indentified proteins are given. 
 
H) The nuclear insoluble fraction of CaCo2 cells was isolated by Nuclear and 
Cytoplasmic Extraction Reagents kit. As we observed previously, this fraction from 
CaCo2 contained 55kDa and 65kDa bands detected by NOX1wch. After acetone 
precipitation a part of the fraction (about 10%) was again used for SDS-PAGE and the 
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second part was used for 2D-GE. NOX1wch detected a strong band at 55kDa and a weak 
band at 65kDa on the PVDF membrane from the SDS-PAGE. However, no dot in the 
range of 55-72kDa could be detected on the PVDF from the 2D-GE. 
    H 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20H: Left panel: Western blot analysis of acetone precipitated proteins in the 
nuclear insoluble fraction from CaCo2 cells employing NOX1wch antibody. Right panel: 
The acetone precipitated proteins in the nuclear insoluble fraction were separated by 2D-
GE, transferred to a PVDF membrane that subsequently was incubated with NOX1wch 
antibody. The pH gradient of the strip for IEF and the molecular weights are labeled. 
 
4.1.12 Effect of NOX1 and NOX4 knock-down on ROS generation  in A549 cells     
The primary function of NADPH oxidase 1 and 4 is ROS generation. We could show that 
NOX1-mRNA is expressed in A549 at a higher level than NOX4-mRNA. Thus our 
further question was, whether NOX1 in A549 cells contributes with a higher extent to 
ROS generation than NOX4. Since the measurement of superoxide anion is problematic 
and superoxide anion is rapidly transformed to hydrogen peroxide, the intracellular ROS 
were measured as concentration of hydrogen peroxide in total cell lysate by Amplex Red 
Hydrogen Peroxide/Peroxidase Assay Kit. Whereas inhibition of NOX1 by siRNA led to 
a significant decrease of ROS levels (decrease more than 20%), NOX4 inhibition was not 
accompanied by any significant decrease in ROS concentration (Figure 21).     
 
 
 
 
Results 
 77
 
 
 
 
 
 
 
 
Figure 21: Effect of NOX1 and NOX4 knock-down by siRNAs on the ROS 
generation in A549 cells   
Measurement of H2O2 concentrations in total cell lysates from A549 cells transfected 
with si-con or si-NOX1 or si-NOX4. The H2O2 concentrations were determined by the 
Amplex Red Hyrogen Peroxide/Peroxidase Assay Kit using excitation/emission wave 
lengths of 540nm/595nm for detection of fluorescence. The fluorescence values were 
always normalized to μg of protein. Significant differences compared to si-con (* p<0.05, 
n=5, unpaired t-test). 
 
4.1.13 Expression of NOX1 and NOX4 under normoxic and hypoxic conditions   
Expression of NADPH oxidase subunits can be influenced by different stimuli, including 
the oxygen concentration. Here, we studied the regulation of NOX1 and NOX4 
expression under different hypoxic conditions. A549 were subjected to hypoxia of 2 
hours (H2), hypoxia of 4 hours (H4), hypoxia of 6 hours (H6), hypoxia of 12 hours  
(H12), hypoxia of 24 hours (H24) and hypoxia of three times 2 hours interrupted by 2 
hours of normoxia (intermittent hypoxia, IH6).  
Real-time RT-PCR revealed significant induction of NOX1 mRNA expression in H24 
and IH6, and no significant changes in H2, H4, H6, H12 groups when compared to 
normoxia (N) (Figure 22A, upper panel). A similar pattern of NOX1 protein expression 
was demonstrated by Western blot analysis of total cell lysate from A549 where NOX1 
was detected as a strong band at 55kDa and a weak band at 65kDa that was most strongly 
increased in H24 and IH6, followed by H12, H6, H4, H2 and N groups (Figure 22A, 
lower panel). On the other hand, NOX4 mRNA expression in A549 did not show any 
significant changes in any of groups subjected to hypoxia when compared to N (Figure 
22B, upper panel). Interestingly NOX4 protein represented by a band at 67kDa appeared 
to be even slightly down-regulated in long term (H24) and intermittent (IH6) hypoxia in 
comparison to N (Figure 22B, lower panel). 
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Figure 22: Expression of NOX1 and NOX4 under normoxic and hypoxic conditions 
A) Upper panel: Quantification of NOX1 mRNA levels in A549 cells subjected to 
normoxic and different hypoxic conditions (for description see Results section) by real-
time RT-PCR. β-actin was used as reference gene. Significant differences compared to N 
(* p<0.05, n=3, unpaired t-test). Lower panel: Western blot analysis of total cell lysates 
from A549 cells subjected to normoxic and different hypoxic conditions employing 
NOX1wch antibody. B) Upper panel: Quantification of NOX4 mRNA levels in A549 
cells subjected to normoxic and different hypoxic conditions by real-time RT-PCR. β-
actin was used as reference gene. Significant differences compared to N (* p<0.05, n=3, 
unpaired t-test). Lower panel: Western blot analysis of total cell lysates from A549 cells 
subjected to normoxic and different hypoxic conditions employing the NOX4jh antibody. 
For Western blots analysis (A, B), 50μg of protein was loaded per well and β-actin was 
used as loading control. 
 
4.1.14 NOX1-derived ROS generation under normoxic and hypoxic conditions 
The previous experiments demonstrated that NOX1 mRNA and protein expression were 
increased after continuous long term hypoxia (H24) and intermittent hypoxia (IH6) 
(Figure 22A). Thus, the further aim was to explore whether the increased NOX1 
expression would correlate with altered ROS levels in the different hypoxic conditions. 
Total cellular ROS were measured as concentration of hydrogen peroxide by Amplex 
Red.  
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Indeed, continuous long term hypoxia (H24) and intermittent hypoxia (H6) displayed 
strong increases of ROS levels. However, also the H12 and H6 groups displayed 
significantly higher levels of ROS in comparison to N (Figure 23A), in spite of the fact 
that NOX1 mRNA was not significantly increased under these conditions. In the next 
step, we investigated the contribution of NOX1 to the ROS generation (Figure 23B). 
A549 cells were transfected by si-NOX1 for 24 hours prior to hypoxia treatments. 
Interestingly, measurement of ROS concentration revealed the strongest dependency of 
ROS on NOX1 in IH6 and H24, that was weaker in the other hypoxic conditions. In 
particular, a decrease of ROS concentration after treatment of cells by si-NOX1 was 
about of 45% in IH6, 37% in H24, 27% H12 and 20% in the other groups. Only in the H4 
group, the ROS level was not decreased significantly after treatment of cells by si-NOX1.    
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Figure 23: Total ROS and NOX1-derived ROS levels under normoxic and hypoxic 
conditions 
A) H2O2 levels in total cell lysates from A549 cells subjected to normoxic and different 
hypoxic conditions. Significant differences compared to N (* p<0.05, ** p<0.01, n=4, 
unpaired t-test).  B) H2O2 levels in total cell lysates from A549 cells transfected with si-
con or si-NOX1 and subsequently subjected to normoxic and different hypoxic 
conditions. Significant differences compared to N (* p<0.05, ** p<0.01, n=3, unpaired t-
test). 
 
4.2 Cross-talk between NOX1 and redox state-dependent transcription factors Nrf2 
and HIF-1 in intermittent hypoxia 
NADPH oxidase 1 is a significant source of ROS in A549 cells. In our work, we could 
show that NOX1, a core subunit of NADPH oxidase 1, was induced under the conditions 
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of continuous long term and intermittent hypoxia (Figure 22A). The increase of NOX1 
abundance was accompanied by elevated ROS level (Figure 23A, B). ROS have impact 
on the activity of several transcription factors including HIF-1 and Nrf2. HIF-1 is 
primarily induced in hypoxia whereas Nrf2 is induced in response to oxidative stress. In 
this context, an important observation was that whereas HIF-1α was stimulated both in 
continuous long term and intermittent hypoxia, Nrf2 was induced only in intermittent but 
not in continuous long term hypoxia (see below, Figure 24A). Additionally, an 
experiment under the same conditions applying si-Nrf2 for the inhibition of Nrf2, 
demonstrated that HIF-1α induction observed in IH6 was dependent on Nrf2 whereas 
induction of HIF-1α in H24 not (see below, Figure 24B). Nevertheless, both transcription 
factors displayed a strong dependency on NOX1 (Doctoral thesis, Shu Li, 2007). Nrf2 is 
a transcription factor regulating the expression of antioxidative enzymes, such as 
thioredoxin 1 (Trx1), which is a well known inductor of HIF-1α. Interestingly, Nrf2 and 
its targets have been described to be up-regulated in the reoxygenation stage after 
hypoxia [202],[203].         
Based on these observations, our further aims were: 
1. To perform detailed analyses of the expression of NOX1, HIF-1α, Nrf2 and Trx1 
under different conditions of oxygenation, particularly in the different stages of 
intermittent hypoxia. 
2. To analyse possible cross-talk(s) between NOX1 and the transcription factors HIF-1 
and Nrf2 in intermittent hypoxia, since under these conditions both factors as well as 
NOX1-derived ROS were induced.  
According to one of our hypothesis, ROS and Trx1 were considered as major mediators 
to link NOX1, Nrf2 and HIF-1α under the performed conditions of intermittent hypoxia  
 
4.2.1 Regulation of HIF-1α and Nrf2 under continuous long term and intermittent 
hypoxia                     
Previous experiments showed that NOX1 and NOX1-derived ROS were most strongly 
increased in IH6 and H24 (Figure 22A, 23B). Since both HIF-1α and Nrf2 are known to 
be regulated by ROS, we firstly analysed the protein expression of these factors in 
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continuous long term (H24) and intermittent hypoxia (IH6), and secondly the impact of 
Nrf2 knock-down by siRNA on HIF-1α.  
Whereas HIF-1α was increased both in IH6 and H24, Nrf2 displayed an elevation only in 
IH6 (Figure 24A). Interestingly, the extent of HIF-1α up-regulation after IH6 and after 
H24 was comparable in spite of the big difference in exposure time to hypoxia (24hours 
in H24 versus three times 2 hours in IH6), indicating the relevance of possible additional 
mechanisms of HIF-1α stimulation under the conditions of intermittent hypoxia. In the 
second experiment, knock-down of Nrf2 caused significantly stronger down-regulation of 
HIF-1α in IH6 than in H24 (Figure 24B), suggesting a regulatory dependence of these 
two transcription factors. 
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Figure 24: Regulation of HIF-1α and Nrf2 under continuous long term and 
intermittent hypoxias  
A) HIF-1α and Nrf2 Western blot analyses of total cell lysates from A549 cells subjected 
to normoxia (N), continuous long term hypoxia (H24) and intermittent hypoxia (IH6).   
B) HIF-1α Western blot analysis of total cell lysates from A549 cells transfected with si-
con or si-Nrf2 and subsequently subjected to H24 and IH6. 40μg of protein was loaded 
per well and β-actin was used as loading control.  
 
4.2.2 Regulation of HIF-1α, Nrf2, Trx1 and NOX1 expression in A549 cells treated 
by different alternating hypoxic and normoxic intervals 
Since NOX1, HIF-1α as well as Nrf2 were strongly induced under the conditions of 
intermittent hypoxia (IH6) (Figure 22A, 24A), we were further interested how the 
individual stages of IH6 influence the expression of these components. Additionally, in 
these experiments, analysis of the Nrf2 target gene Trx1 was included.  
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For this purpose, A549 cells were incubated in different sequences of normoxic and 
hypoxic intervals (Figure 25A) as follows: Normoxia (N), hypoxia for 2 hours (H2), 
hypoxia for 2 hours followed by reoxygenation for 2 hours (H2R), intermittent hypoxia 
for twice 2 hours interrupted by 2 hours of normoxia (IH4), intermittent hypoxia IH4 
followed by 2 hours of reoxygenation (IH4R), intermittent hypoxia for three-times 2 
hours interrupted twice by 2 hours of normoxia (IH6) and hypoxia for 6 hours (H6). HIF-
1α was most strongly induced in IH6 and H6, induced to a lesser degree in IH4 and H2, 
whereas in N, H2R and IH4R, the HIF-1α signal was barely detectable (Figure 25B). 
HIF-1α was usually detected as a double-band by Western blot, most likely reflecting 
different phosphorylation states, as described previously [204]. Expression of both Nrf2 
and Trx1 was up-regulated in IH4R and IH6 (Figure 25B). Nrf2 was detected as a 110 
kDa band described previously [202, 205]. Expression of the NADPH oxidase subunit 
NOX1 was enhanced in IH4, IH4R and IH6 when compared to N (Figure 25B). NOX1 
was detected as a band at 55kDa. The 65kDa band that we observed previously was 
barely detectable in the total cell lysate of A549 cells and therefore it could not be 
considered for Western blot evaluation. The identity of Nrf2 and NOX1 protein bands 
were further supported by specific inhibition with siRNA as described above and below. 
Employing real-time RT-PCR, we could determine increased expression of Trx1 mRNA 
in IH4R, IH6 and of NOX1 mRNA in IH4, IH4R and IH6 (Figure 25C) which is 
consistent with the increased protein abundance of Trx1 and NOX1. Expression of HIF-
1α mRNA and Nrf2 mRNA was not affected (data not shown), revealing that the 
different oxygenation conditions affect these factors directly at the protein expression 
level. 
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Figure 25: Regulation of HIF-1α, Nrf2, Trx1 and NOX1 expression in A549 cells 
treated by different alternating hypoxic and normoxic intervals  
A) Scheme of the intervals under which the cells were cultured (for description see 
Results section). B) Western blot of HIF-1α, Nrf2, Trx1, NOX1 and β-actin (used as 
loading control). C) Quantification of Trx1 and NOX1 mRNA levels by real-time RT-
PCR. Significant differences compared to N (* p<0.05, ** p<0.01, n=3, unpaired t-test). 
 
4.2.3 Reactive oxygen species in A549 cells treated by different alternating hypoxic 
and normoxic intervals  
The previous experiments showed increased expression of NOX1 mRNA and protein in 
different stages of IH6 (Figure 25B, C). Thus, we further tested whether theses changes 
in NOX1 expression would be reflected by alterations of ROS levels under the given 
oxygenation conditions.  
Levels of ROS were most significantly elevated in H6 and IH6 followed by IH4 and 
IH4R when compared to normoxia (Figure 26A). In order to analyze the contribution of 
NOX1 to the alterations of ROS generation observed in different oxygenation conditions, 
we performed inhibition of NOX1 by siRNA in comparison to a random siRNA 
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employed as a control. The validation of the inhibition of NOX1 by si-NOX1 at the 
protein and mRNA level was shown at Figure 14A. The most significant dampening of 
ROS generation was observed in cells treated with si-NOX1 compared to si-con in the 
IH6 group (by approximately 45 %), less dramatic effects on ROS generation by si-
NOX1 treatment were noticed in N, H2R, IH4 and IH4R, whereas the effects of H2 and 
H6 did not reach significance (Figure 26B). This indicates that NOX1 is important for 
ROS generation in conditions of intermittent hypoxia, while less relevant under 
conditions of stable oxygen levels.  
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Figure 26: Total ROS and NOX1-derived ROS levels in A549 cells treated by 
different alternating hypoxic and normoxic intervals  
A) H2O2 levels in naïve cells (* p<0.05, ** p<0.01, n=3, unpaired t-test). B) H2O2 levels 
after inhibition of NOX1 by si-NOX1 compared to si-con (* p<0.05, ** p<0.01, n=3, 
unpaired t-test). 
 
4.2.4 Regulation of Nrf2 by NOX1  
Next, we characterized the relevance of NOX1 generated ROS for cell signaling with 
regard to Nrf2 activation. This experiment was based on non published data of our group 
demonstrating that NOX1 inhibition decreased the Nrf2 transcription activity measured 
by ARE reporter gene assay (Doctoral thesis, Shu Li, 2007). Also we could show that 
inhibition of NOX1 by si-NOX1 or DPI (a NADPH oxidase inhibitor) strongly down-
regulated Nrf2 at the protein level (Figure 27A). These experiments also included direct 
inhibition of Nrf2 by si-Nrf2 performed as a control. Furthermore, the inhibitory effect of 
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si-NOX1 and DPI on Nrf2 was confirmed at the Nrf2 target gene level employing an 
ARE reporter gene assay (Figure 27B). Down-regulation of Nrf2 by si-NOX1 could be 
prevented by the addition of the proteasome inhibitor MG-132, suggesting that NOX1-
derived ROS interfere with the redox-dependent proteosomal degradation of Nrf2 (Figure 
27C). Furthermore, real-time RT-PCR demonstrated that inhibition of NOX1 did not 
effect Nrf2 mRNA (data not shown) indicating that NOX1 controls Nrf2 directly at the 
protein levels.  
To further confirm these results, we investigated the effect of NOX1 overexpression on 
Nrf2. Overexpression of NOX1 resulted in induction of Nrf2 as demonstrated by Nrf2 
Western blot (Figure 27D, upper panel, left) and ARE reporter gene assay (Figure 27D, 
lower panel, left). Overexpression of NOX1 was validated by Western blot employing an 
HA-antibody for the detection of the HA-tagged NOX1 (Figure 27D, upper panel, right). 
Furthermore, also measurement of ROS (H2O2) concentrations by Amplex Red displayed 
significantly higher H2O2 level in cells transfected with NOX1-HA containing plasmid in 
comparison to empty vector (Figure 27D, lower panel, right).     
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Figure 27: Regulation of Nrf2 by NOX1 in A549 cells  
A) Western blot analysis of Nrf2 and B) ARE reporter gene analysis of Nrf2-dependent 
target genes in A549 cells transfected with si-NOX1 and with si-Nrf2 compared to si-con 
(left) and A549 cells treated by the NADPH oxidase inhibitor DPI (1 µM) or the solvent 
DMSO, which was used as control (right) (* p<0.05, ** p<0.01, n=3, unpaired t-test).   
C) Western blot analysis of Nrf2 in A549 cells transfected with si-NOX1 compared to si-
con and treated by the proteasome inhibitor MG132 (25μM) or solvent DMSO used as 
control. D) Western blot analysis of Nrf2 (upper panels, left), and ARE reporter gene 
assay analysis (lower panels, left) in A549 cells transfected with tagged NOX1-HA or 
empty plasmid. Expression of NOX1-HA was validated by Western blot employing an 
HA antibody (upper panel, right) and by measurement of H2O2 concentration by Amplex 
Red (lower panel, right) (** p<0.01, n=3, unpaired t-test).  
 
4.2.5 Regulation of Trx1 expression by NOX1  
Next, we analyzed the effect of NOX1 on Trx1, a target gene of Nrf2. Accordingly, si-
NOX1 treatment decreased Trx1 at the protein level as demonstrated by Western blot 
(Figure 28A) and mRNA level as demonstrated by real-time RT-PCR suggesting a 
transcription dependent regulation of Trx1 by NOX1 (Figure 28B). Also, these 
experiments included the inhibition of Nrf2 by si-Nrf2, and of Trx1 by si-Trx1 that were 
performed as controls (Figures 28A, B). Vice verse, NOX1 overexpression increased 
Trx1 at the protein level (Figure 28C). In order to prove that NOX1-dependent Trx1 
regulation is mediated by Nrf2, we concomitantly overexpressed NOX1 and inhibited 
Nrf2 by siRNA (Figure 28D). Indeed, the NOX1-dependent induction of Trx1 was 
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completely abolished by Nrf2 inhibition which indicates that Nrf2 is the critical factor for 
Trx1 regulation by NOX1.   
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Figure 28: Regulation of Trx1 expression by NOX1 in A549 cells 
 A) Western blot analysis of Trx1 and B) real-time RT-PCR of Trx1 mRNA after 
inhibition of NOX1 by si-NOX and of Nrf2 by si-Nrf2 compared to si-con (* p<0.05, ** 
p<0.01, n=3, unpaired t-test). Trx1 inhibition by siRNA is included as a control.            
C) Western blot analysis of Trx1 from cells transfected by NOX1-HA plasmid compared 
to empty plasmid. D) Western blot analysis of Trx1 concomitantly transfected with 
empty plasmid or NOX1-HA plasmid and si-Nrf2 or si-con.  
 
4.2.6 Regulation of Nrf2 and Trx1 expression by NOX1 under conditions of 
hypoxia-reoxygenation and intermittent hypoxia 
The previous experiments revealed that Nrf2 and Trx1 expression depends on NOX1 
under normoxic conditions (Figures 27 and 28). Initially, we observed a strong increase 
in Nrf2 and Trx1 expression in IH4R and IH6 (Figure 25B, C). Also, an up-regulation of 
NOX1 expression was observed in IH4R and IH6 (Figure 25B, C). Furthermore, NOX1-
dependent ROS generation was more pronounced under these conditions (Figure 26B). 
Thus, we investigated the impact of NOX1 on Nrf2 and Trx1 in IH4R and IH6 (Figure 
29). For this purpose, cells were transfected with si-con or si-NOX1 and subsequently 
Nrf2 and Trx1 expression was analyzed by Western blot. Indeed, si-NOX1 treatment 
caused most strong inhibition of Nrf2 and Trx1 under conditions of IH4R and IH6. In 
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particular, the Nrf2 and Trx1 protein decreased to the levels observed in normoxia after 
si-NOX1 treatment. 
 
 
 
 
 
 
 
 
Figure 29: Regulation of Nrf2 and Trx1 expression by NOX1 under conditions of 
hypoxia-reoxygenation and intermittent hypoxia 
Western blot analysis of Nrf2 and Trx1 after inhibition of NOX1 by si-NOX1 compared 
to si-con under conditions of IH4R and IH6 compared to N.  
 
4.2.7 Regulation of HIF-1α by Nrf2, Trx1 and NOX1 under conditions of continuous 
and intermittent hypoxia 
In the next step, we analyzed the effects of the inhibition of Nrf2, Trx1 and NOX1 on 
HIF-1α after continuous and intermittent hypoxic exposure (H2, H6, IH6). Treatment of 
cells with si-Nrf2, si-Trx1 and si-NOX1 resulted in significant down-regulation of HIF-
1α expression in IH6, an effect that was less apparent in H2 and H6 as demonstrated by 
Western blot (Figure 30A) and HRE reporter gene assay (Figure 30B). IH6 displayed 
increased HIF-1 activity in comparison to H6 (Figure 30B, comparison of si-con (H6) to 
si-con (IH6), however this increase was not significant.   
Furthermore, we demonstrated that overexpression of Trx1 induced HIF-1α both in 
continuous (H2, H6) and in intermittent hypoxia (IH6) (Figure 30C). Thus, increased 
Trx1 protein abundance (as observed endogenously in IH6) appears to be sufficient for 
the induction of HIF-1α, independently of other HIF-1α regulating mechanisms 
occurring in intermittent or continuous hypoxia. Also, these effects were evident when 
performing the HRE-dependent reporter gene assay measuring the accumulation of HIF-
dependent target gene expression over the entire time periods studied (Figure 30D).  
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Figure 30: Regulation of HIF-1α by Nrf2, Trx1 and NOX1 under conditions of 
continuous and intermittent hypoxia  
A) Western blot analysis of HIF-1α and B) HRE reporter gene assay in A549 cells after 
inhibition of Nrf2, Trx1 and NOX1 by si-Nrf2, si-Trx1, si-NOX1 compared to si-con 
under conditions of H2, H6 and IH6 (* p<0.05, ** p<0.01, n=3, unpaired t-test). C) 
Western blot analysis of HIF-1α and D) HRE reporter gene assay in A549 cells after 
transfection of Trx1 plasmid or empty plasmid (as validated by Trx1 Western blot) under 
conditions of H2, H6 and IH6 (* p<0.05, n=3, unpaired t-test). 
Results 
 90
4.2.8 Signaling pathway of NOX1 and Trx1 causing induction of HIF-1α in 
intermittent hypoxia 
The following sequence of events causing the Nrf2-dependent induction of HIF-1α in 
intermittent hypoxia is suggested by our experiments: NOX1 induction in intermittent 
hypoxia causes an ROS elevation that subsequently induces Nrf2. In turn, Nrf2 induces 
its target Trx1 that leads to the induction of HIF-1α. In order to investigate whether Trx1 
is the relevant downstream target of NOX1 enhancing HIF-1α in intermittent hypoxia 
(IH6), we performed both HIF-1α Western blot and HRE reporter gene assay from cells 
transfected with empty- or NOX1- or Trx1-plasmids and concomitantly with si-con or si-
NOX1 or si-Trx1 (Figure 31A). Both overexpression of Trx1 (lane 2) and NOX1 (lane 3) 
displayed the typical induction of HIF-1α compared to the control (lane 1). Treatment of 
cells with si-NOX1 (lane 4) and si-Trx1 (lane 5) displayed down-regulation of HIF-1α 
expression compared to the control (lanes 1). However, treatment with si-NOX1 in Trx1-
overexpressing cells (lane 6) did not result in the inhibition of HIF-1α, whereas treatment 
with si-Trx1 in NOX1-overexpressing cells (lane 7) was effective in the inhibition of 
HIF-1α, revealing that NOX1 is most likely upstream of Trx1. These HIF-1α Western 
blot results were in accordance with the HRE reporter gene assay organized exactly in the 
same way (Figure 31B). In particular, treatment of NOX1-overexpressing cells with si-
Trx1 (lane 7) prevented the HRE induction (no significant induction compared to lane 1). 
In conclusion, the experiments strongly support a signal transduction pathway (Figure 
32), that is relevant for HIF-1α induction under the given conditions of intermittent 
hypoxia. 
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Figure 31: Signaling pathway of NOX1 and Trx1 causing the induction of HIF-1α 
after intermittent hypoxia exposure 
A) Western blot analysis of HIF-1α and B) HRE reporter gene analysis in A549 cells 
transfected with empty or Trx1 or NOX1-HA plasmids with concomitant inhibition of 
NOX1 or Trx1 by si-NOX1 and si-Trx1 (* p<0.05, ** p<0.01, n=3, unpaired t-test). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32: Schematic diagram of the regulation of HIF-1α by NOX1, Nrf2 and Trx1 
during intermittent hypoxia exposure of A549 cells 
ROS generated by NADPH oxidase 1 during intermittent hypoxia increase Nrf2 protein 
abundance likely by disruption of its interaction with Keap1. Nrf2 induction leads to 
enhanced Trx1 expression that subsequently stimulates HIF-1α . Alternatively, ROS may 
directly regulate Nrf2, Trx1 and HIF-1α by different mechanisms such as alteration of 
the redox state of the target molecules, phosphorylation or enhancement of translation.    
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5. Discussion 
5.1 Detection of NOX1 and NOX4 proteins and analysis of NOX1- and NOX4-
dependent ROS generation  
In the first part of the work, we attempted to select the most suitable antibodies for the 
detection of NOX1 and NOX4 proteins since immuno-detection of these proteins is a 
commonly faced problem which complicates further structural and functional 
characterization of NOX1 and NOX4. Thus, several commercial and custom-made 
NOX1 and NOX4 antibodies were employed for Western blot analyses of total cell 
lysates and fractions of different cell compartments of A549 and other cell types 
expressing high levels of NOX1 or NOX4. In parallel with these approaches, we 
developed efficient siRNAs for specific knock-down of NOX1 and NOX4, and also 
attempted to purify and identify some of NOX1 and NOX4 proteins by HPLC/2D-GE 
followed by MALDI-TOF MS. Finally, we characterized the relative contribution of 
NOX1 and NOX4 to ROS generation in A549 cells. 
 
5.1.1 Detection and analysis of cellular localization of NOX1 and NOX4 proteins 
using different antibodies 
5.1.1.2 NOX1 
The NOX1 antibodies immunoreactive proteins were analyzed in A549 and CaCo2 cells. 
Both cell types (but particularly CaCo2) are suggested to express considerable levels of 
NOX1. In accordance to our studies, CaCo2 cells displayed a higher NOX1 mRNA level 
than A549 cells as detected by real-time RT-PCR (Figure 8A). Five different NOX1 
antibodies were employed for the detection of NOX1. However, no common bands in the 
range of the predicted NOX1 size could be detected with these antibodies (Figure 10A 
and 11A). The predicted molecule weight from the open reading frame sequence of 
NOX1 is 65kDa. However, commonly detected bands have been observed in the range of 
50-65kDa [14], [15], [16], [17], [18], [19]. Deviations from the predicted NOX1 
molecular weight may have different reasons:  
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1. altered migration of NOX1 proteins in SDS-PAGE based on their specific physical-
chemical properties 
2. cleavage of an N-terminal signal peptide or other proteolytic processing of NOX1 
3. translation from different start codons in the NOX1 mRNA  
4. alternative splice products of the NOX1 gene  
5. immunoreactive NOX1 antibodies bands not related to NOX1 
 
The characteristic immunoreactive patterns of the different NOX1 antibodies employed 
in Western blots are described below.   
NOX1wch  
NOX1wch (Dr.W.Chamulitrat, University Heidelberg) was the only antibody that 
detected some bands near to the predicted size of NOX1, both in total cell lysate and 
subcellular fractions of both  A549 and CaCo2 cells. Finally, this polyclonal antibody 
appeared to be the most suitable antibody for the detection of NOX1. It was developed 
against a synthetic NOX1-derived peptide (Figure 9A) that was used also by other groups 
for raising NOX1 antibodies [206], [207], [208], [209]. In particular, NOX1wch detected 
bands at 55kDa and 65kDa that were more strongly abundant in CaCo2 than in A549 
cells. The sizes of these bands were the same as those detected in immortalized human 
gingival keratinocytes using this antibody [29], [14].  
When different techniques for subcellular fractionation were used, both the 55kDa and 
65kDa bands were localized predominantly in the cytoskeleton of A549 and CaCo2 cells 
(Figure 11A, 12A, 16A). The detection of these proteins in a particular fraction also 
depended on the method of fractionation and was not always consistent. For example, 
when the Complete Cell Fractionation Kit was used the 55kDa and 65kDa bands were 
strongly present in the cytoskeleton and weakly in the nuclei of these cell lines (Figure 
11A). When the Nuclear and Cytoplasmic Extraction Reagent was employed, the 65kDa 
band of CaCo2 cells was mainly detected in the nuclear insoluble fraction representing 
the cytoskeleton and the 55kDa band was also strongly present in the nuclear soluble 
fraction representing nuclear proteins (Figure 16A). However, when the same kit was 
used for A549 cells, the 65kDa band was mainly in the nuclear insoluble fraction but the 
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55kDa band was detected only in the nuclear soluble fraction (Figure 16A). These 
inconsistent observations make it difficult to draw clear conclusions regarding the 
accurate subcellular localization of NOX1.                            
The strong cytoskeletal and the weak nuclear NOX1 localizations appear to be in contrast 
to previous reports, where NOX1 was commonly detected in the plasma membrane [27], 
[21], [22], [23],  [24]. Interestingly, the NOX1 homologs NOX2 and NOX4 were both 
found in the Tx-100 insoluble fraction (containing mainly cytoskeleton proteins) and 
NOX4 was also colocalized with focal adhesions [210], [18]. The subcellular localization 
of these homologs seems to be dependent on the type of cells. For example, in 
neutrophils NOX2 associates with the plasma membrane [211], [212], whereas in 
HUVEC NOX2 is predominantly localized intracellular at the cytoskeleton and in the 
nuclei [210]. However in our experiments, NOX1wch detected bands in both A549 and 
CaCo2 cells in the cytoskeleton but not in the membrane fraction. One current study from 
Gianni et al. is partially supporting our observations. This study has shown that 
recombinant NOX1 is colocalized with F-actin and cortactin in invadopodia (i.e. 
protrusion in the plasma membrane) of DLD1 colon cancer cells [28]. Interestingly, also 
our experiments with recombinant NOX1 demonstrated that HA-tagged NOX1 protein 
was localized mainly in the Tx-100 insoluble fraction (Figure 15A). One possible 
explanation of this observation could be that NOX1 is localized in the plasma membrane 
where it interacts with the cytoskeleton or focal adhesions and thus it may be difficult to 
recover NOX1 from the membrane fraction (i.e. to separate it from the cytoskeleton) by 
common biochemical techniques. Additional approaches such as immunocytology 
employing suitable antibodies for the analysis of NOX1 protein localization could be 
helpful in this regard. However, this approach was not applicable with NOX1wch since 
several additional proteins of lower molecular weight were detected with this antibody. 
Also, detection of recombinant NOX1-HA with HA-antibody was not applicable since it 
displayed several degradation products that might interfere with the localization of 
NOX1-HA “full length” protein.     
NOX1wch typically detected bands at 55kDa and 65kDa. The band at 55kDa in A549 
and CaCo2 cells was stronger than the 65kDa band. Both bands were sensitive to si-
NOX1 treatment (Figure 14A), thus both these proteins were considered as NOX1. The 
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55kDa band was unlikely representing NOX1v (i.e. NOX1 splice variant, Mw = 59kDa) 
since, firstly, this variant was almost undetectable at the mRNA level in A549 and CaCo2 
cells and secondly, one previous study showed that transfection of immortalized human 
gingival keratinocytes by recombinant NOX1 increased the abundance of both the 65kDa 
and 55kDa bands when using the NOX1wch antibody [14]. Thus, the 55kDa band may 
rather represent an endogenous proteolyticly processed product, for example, after signal 
peptide cleavage as suggested by Helmecke et al. [21]. However, the predicted signal 
peptide of NOX1 protein would contain the first 29 amino acids of the N-terminus 
(ExPASy Proteomics Server, Post-translational modification prediction), which does not 
fit to the difference of 10kDa between the predicted size of 65kDa and the detected of 
55kDa. An additional explanation of this observation could be based on the physical-
chemical properties of the NOX1 protein. Proteins containing membrane domains are 
typically migrating faster in SDS-PAGE since they may bound higher amount of SDS 
[213]. Signal peptide cleavage could alter the hydrophobicity of NOX1 and thus 
proteolyticly processed NOX1 would migrate faster than the non-processed. The 
presence of two differently processed NOX1 proteins (55 and 65kDa) may affect NOX1 
localization and function. In this context is interesting, that deglycosylation of NOX1 
homolog NOX2, that in glycosylated form migrates as a 91kDa protein, shifted the 
apparent molecular weight not to the predicted 65kDa but to 55kDa [214], [215].                    
A further explanation could be that different start codons of NOX1 mRNA for translation 
are functional. In fact, if the translation of NOX1 mRNA would start at the second start 
codon (Met-107) in frame, the protein would have a size of 53kDa. However, this start 
position is speculative since the second AUG unlike the first one does not exhibit any 
Kozak-related sequence (A/GxxAUGG) that would favour initiation of translation at this 
position (Molecular biology of the cell, Alberts et al., 2002).  
Thus, in the next part of our work, we performed proteomic analyses in order to get more 
information about the amino acid sequence and identity of these two proteins.  
In sum, NOX1wch detected protein bands near to the predicted size of NOX1 (55kDa 
and 65kDa) both in A549 and in CaCo2 cells. Both proteins were stronger expressed in 
CaCo2 than in A549 cells (Figure 10A). These bands were sensitive to inhibition by 
specific si-NOX1 (Figure 14A). Furthermore, this antibody detected fragments of the 
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NOX1 recombinant protein (Figure 15A). We concluded that this antibody was the most 
suitable for NOX1 protein detection in Western blot when compared to the other 
antibodies.  
NOX1ab55831  
NOX1ab55831 (Abcam) detected a band at position of 60kDa. However, this band was 
considered to be unlikely NOX1 since, firstly, it was expressed in A549 cells at a higher 
level than in CaCo2 cells (Figure 10A, 11A, 12A), secondly, it was present in the 
cytosolic fraction (Figure 11A, 13A) and thirdly this protein was not sensitive to siRNA 
mediated NOX1 knock-down (Figure 14A). Also treatment of samples with Tx-100 did 
not show any changes in the localization of this protein (Figure 12A), which indicated 
that this protein was not membrane associated.     
MOX1 H-15  
MOX1 H-15 (Santa Cruz Biotechnology) is a frequently used antibody for the detection 
of NOX1 [200], [20] [201], [216], [217], [21], [218]. This antibody interacted with the 
NOX1 recombinantly expressed protein (data not shown) however the detection of 
endogenous NOX1 was problematic. Employing an older batch of MOX1 H-15, a band at 
60kDa was detected in the cytosolic fraction of A549 (Figure 19, 110000g supernatant). 
This band seemed to be identical with the 60kDa band detected with NOX1ab55831 
since both antibodies have been raised against peptides that had overlaping amino acid 
sequences (Figure 9A). However with the new batch of the antibody, the band at 60kDa 
was undetectable in total cell lysate (Figure 10A) and weakly detectable in cell fractions 
(Figure 11A). In contrast, the new batch of MOX1 H-15 visualized a band at 68kDa in 
the nuclear fraction both in A549 and CaCo2 (Figure 11A) cells. However, because this 
band was not detected in the total cell lysate, the antibody was not useful for further 
validation such as the inhibition of NOX1 by siRNAs.   
MOX1 H-75  
MOX1 H-75 (Santa Cruz Biotechnology) was described to detect recombinant NOX1 in 
one study [219]. In our studies, the antibody detected a band at 50kDa (Figure 10A, 11A) 
- an observation that was not always reproducible (Figure 12A). This antibody was raised 
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to a relative long peptide of 75 amino acids at the N-terminal part of NOX1, and thus it is 
more likely that the antibody detects also related proteins.                        
NOX1jh  
NOX1jh (Dr.J.Hänze, University Giessen) antibody detected a band at 95kDa in both cell 
types, however at a higher level in A549 than in CaCo2 cells (Figure 10A). This band 
was very strong and was detectable in cytosolic, membrane and nuclear fractions (Figure 
11A). Tx-100 treatment appeared to release the protein from the pellet to the supernatant 
which may indicate that it was a membrane associated protein (Figure 12A). Based on its 
molecular weight (95kDa), the protein could represent a dimer of NOX1 with p22phox 
but this explanation seems to be unlikely since reducing and denaturing conditions should 
disrupt the interaction of NOX1 and p22phox. Also, si-NOX1 treatment did not decrease 
the level of this protein (Figure 14A).  
A polyclonal antibody raised against the identical NOX1-derived peptide as NOX1jh was 
also used by another group. However, in this study the antibody functionality was not 
properly validated [19].  
 mAb54.1  
mAb54.1 (Dr.J.Buritt, Montana State University, USA) is a monoclonal antibody raised 
against a NOX2-derived peptide. This antibody is well established for the detection of 
NOX2 [220], [221], [222], [223]. In addition, one study showed that mAb54.1 also 
detected fragments of recombinant proteins of NOX1, NOX3 and NOX4 [199]. This was 
likely based on similarities in the amino acid sequences between different NOX proteins 
in the epitop that was used as immunoreactive peptide. This antibody detected a strong 
band at 55kDa (Figure 10A) that was previously determined as GRP 58 [199]. When 
subcellular fractionation was performed, the mAb54.1 was the only antibody detecting 
proteins close to 65kDa in the membrane fraction of A549 cells (Figure 11A). Since this 
protein was almost not present in the membrane of CaCo2 cells, we supposed that it 
represents rather NOX2 than NOX1. Limited amount of mAb54.1 did not allow to 
perform further experiments with this antibody.         
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5.1.1.3 NOX4 
Three different NOX4 antibodies were employed for the detection of NOX4 in A549 
cells and HUVEC in our study. HUVEC were used as a positive control for NOX4 
expression since these cells have been described to express high level of NOX4 [65], 
[74], [224]. Indeed, NOX4 mRNA analysis by real-time RT-PCR revealed higher level of 
NOX4 mRNA in HUVEC than in A549 cells (Figure 8B). Employing different NOX4 
antibodies, bands near to the predicted size of 67kDa and an additional band in the range 
of 75-80kDa have been commonly detected [60], [18], [61], [62], [63], [64]. The higher 
molecular weight may represent posttranslational modifications of NOX4. In fact, several 
N-glycosylation sites in NOX4 protein are predicted (ExPASy Proteomics Server, Post-
translational modification prediction). However, treatment of the cell lysate with N-
glycosidase F did not reduce the molecular weight of the 80kDa band [60] making N-
glycosylation of NOX4 not very likely. Thus, the reason of this shift in molecular weight 
of NOX4 remains unexplained.  
Similarly to the NOX1 antibodies, comparison between the different NOX4 antibodies 
revealed no common band in Western blot analysis of cell lysates from A549 cells and 
HUVEC. The characteristic immunoreactive patterns of the different NOX4 antibodies 
are presented below.  
 
NOX4jh  
NOX4jh (Dr.J.Hänze, University Giessen) turned out to be the most suitable antibody for 
NOX4 detection. This antibody detected bands at 62kDa and 67kDa in A549 cells and 
bands at 50kDa, 67kDa and 80kDa in HUVEC (Figure 10B). In addition, several protein 
species of lower molecular weight were observed. In contrast to the 62kDa band, the 
67kDa band was efficiently inhibited by NOX4 siRNA (Figure 14B) supporting the 
identity of this band as NOX4. In accordance with some previous studies [18], [64], [66] 
the NOX4 67kDa band was found in the cytoskeleton fraction of A549 cells (Figure 11B, 
12B). Interestingly when fractions from HUVEC were analysed, NOX4 was present in 
the cytoskeleton and in the nuclear fraction (Figure 11B). This was confirmed by 
isolation of the nuclear fraction employing different kit systems (Figure 16B). The NOX4 
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localization in nuclei was also observed by other groups [65], [18], [62]. Accordingly, the 
isolation of Tx-100 soluble and insoluble fractions revealed NOX4 both in the 
supernatant and pellet in HUVEC but only in the pellet of A549 cells (Figure 12B). These 
different results of the biochemical separation between A549 cells and HUVEC may also 
be caused by different solubility of the cytoskeletons. In contrast to our results, other 
groups demonstrated that NOX4 is localized in the ER [21], [62], [25]. This may be 
explained by different localization of NOX4 in dependency on the cell type or on 
presence of different isoforms (splice variants) of NOX4 in cells or on NOX4 
posttranslational modification(s) or by use of different techniques for analysis of 
subcellular localization of NOX4 or by a low specificity of the antibodies. In HUVEC 
cells we observed an additional 80kDa NOX4 band that was present in the cytosolic but 
not in the membrane or cytoskeleton fraction (Figure 11B) (confirmed also by separation 
of Tx-100 soluble and insoluble fraction, Figure 12B). In contrast to our results, one 
recent study described the 80kDa band as NOX4 that was localized in focal adhesions, 
stress fibres and nuclei [64], and another study that demonstrated this band localized both 
in Tx-100 soluble and insoluble fractions [18].  
In order to identify all NOX4jh antibody immunoreactive bands that may represent 
different posttranslational modifications or splice variants of NOX4, further proteomic 
analyses of these proteins were performed. 
In sum, the NOX4jh antibody was suitable for the detection of NOX4 protein since it 
reacted with a band of the expected 67kDa (Figure 10B) and this band was sensitive to 
knock-down by si-NOX4 (Figure 14B). Moreover, the 67kDa protein was stronger 
expressed in HUVEC than in A549 cells (Figure 10B) which was in accordance with 
NOX4 mRNA quantification in these types of cells (Figure 8B). 
NOX4 N-15 & NOX4 H-300  
Also, the antibodies NOX4 N-15 and NOX4 H-300 (Santa Cruz biotechnology) were 
employed for the analysis of expression of potential NOX4 proteins. However, these 
antibodies did not detect any band in common with NOX4jh. Additionally, these 
antibodies turned out not to be very sensitive since they did not detect any strong band in 
the total cell lysate (Figure 10B). NOX4 N-15 has been described to detect NOX4 in 
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several studies [201], [200], [216], [217]. However, in our experiments, not any bands 
were detected at all. The reasons for this are not clear. In contrast to NOX4 N-15, NOX4 
H-300 detected a few bands near to the predicted size of NOX4 in subcellular fractions of 
A549 cells but not of HUVEC (Figure 11B). NOX4 H-300 was used in one recent study. 
However, in this study the immunoreactivity of the antibody with NOX4 protein was not 
clearly confirmed [224].      
In conclusion, NOX4 N-15 and NOX4 H-300 were not useful for the detection of NOX4 
in our Western blot experiments.                      
 
 5.1.2 Detection of p22phox and NOXO1 proteins in different cell compartments  
p22phox and NOXO1 are essential components for NADPH oxidase 1 function. Their 
expressions were analysed along with NOX1 by Western blot. Previous studies 
demonstrated that p22phox is localized in different cell membranes [26], [225], [226], 
[24], [212] and NOXO1 in the plasma membrane and cytosol [226], [24], [23]. 
Accordingly, we detected p22phox mainly in the membrane (Figure 11C, 13A) and the 
nuclear fraction (Figure 11C). The membrane association of p22phox was also suggested 
from experiments where Tx-100 treatment of cell lysate released p22phox at least 
partially into the supernatant (Figure 12C). The non complete release of p22phox from 
the pellet after treatment by Tx-100 suggested that p22phox also interacted with 
components of the cytoskeleton. Also, Li et al. [210] observed p22phox in the Tx-100 
insoluble fraction of HUVEC. Additionally, our experiments showed that p22phox was 
almost not present in the pure plasma membrane fraction of A549 cells (Figure 13A) 
which indicates that also NOX1 should not be in this fraction since p22phox-NOX1 
interaction is important for the function of NADPH oxidase 1 [26], [25].  
The NOXO1 antibody detected a band with a molecular weight of the expected 41kDa 
(emerging sometimes as a double band) and no further bands were visible. Employing 
several approaches, our studies demonstrated NOXO1 mainly in the cytoskeleton fraction 
(Figure 11C, 16C). Tx-100 treatment partially released NOX1 from the cytoskeleton 
indicating a possible association of NOXO1 with membranes (Figures 12C). The 
localization of NOXO1 in the cytoskeleton fraction was in accordance with the NOX1 
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localization (using NOX1wch antibody) and supports the functional interaction between 
these two proteins. 
 
5.1.3 Effect of p22phox knock-down on NOX1 and NOX4 stability 
p22phox is also suggested to stabilize NOX proteins during their folding in the ER. It has 
been shown that p22phox is critical for maturation and function of NOX2 [78], [77], [82]. 
An inhibitory effect of p22phox knock-down on recombinant NOX1 but not NOX4 
protein expression has also been demonstrated [82]. Thus, our further aims were to 
investigate effect of p22phox knock-down on expression of proteins that we determined 
as NOX1 and NOX4 and vice-versa, effect of NOX1 and NOX4 knock-down on 
p22phox protein expression. 
An inhibition of p22phox by specific siRNA did not display any effect on the expression 
levels of endogenous NOX1 and NOX4 proteins (Figure 17A). When the same 
experiment with recombinantly expressed NOX1 and NOX4 proteins was performed, the 
down regulatory effect of p22phox inhibition on NOX1 and NOX4 proteins levels was 
strongly apparent (Figure 17B). This effect was partially cancelled by treatment of cells 
with a proteasome inhibitor (MG132) indicating that p22phox influences NOX1 and 
NOX4 protein stability by proteasome degradation. Conversely, inhibition of NOX1 but 
almost not of NOX4 led to a decrease of p22phox protein expression (Figure 17C). 
Theses results indicate that p22phox is important for NOX1 and NOX4 protein 
stabilization under the conditions when NOX1 and NOX4 protein synthesis is induced, 
and secondly, that NOX1 is more important than NOX4 for stabilization of p22phox 
protein in A549. The second observation may be based simply on the fact that in A549 
cells NOX1 is expressed at a much higher level than NOX4 (Figure 8C, comparison of 
quantity of NOX1 and NOX4 mRNAs in A549 cells) and thus NOX1 may be more 
important than NOX4 for p22phox stabilization.  
 
5.1.4 Purification of putative NOX1 and NOX4 proteins  
Different NOX1 antibodies displayed different patterns of NOX1 immunoreactive bands. 
The NOX1wch antibody detected two specific bands of 55kDa and 65kDa in A549 cells. 
Discussion 
 102
The NOX4jh antibody detected at least two specific bands of 67kDa and 80kDa in 
HUVEC. Furthermore, both antibodies detected several additional bands of lower 
molecular weights that also may represent NOX proteins. Thus, we aimed to further 
identify all these bands by proteomic approaches.  
Isolation of the proteins bands after subcellular fractionation from the polyacryl-amid gel 
or PVDF membrane did not allow the identification of NOX related proteins by MALDI-
TOF MS analysis. This was likely because of the low abundance and purity of the 
investigated proteins in single bands isolated from the polyacryal-amid gel or PVDF 
membrane. Thus, we performed several additional purification steps. After subcellular 
fractionation, two HPLC purification steps were performed, i.e. anion exchange 
chromatography (AEC) and reverse phase chromatography (RPC), followed by Western 
blot analysis of all HPLC fractions and final analysis of the relevant proteins bands 
isolated from the gel or PVDF membrane by MALDI-TOF MS. An alternative 
purification procedure included 2D gel electrophoresis (2D-GE) instead of one or both 
HPLC purification steps. The strategy of purification is depicted on Figure 18. 
However, in spite of performing these additional purification steps, we did not identify 
any of the immunoreactive bands as NOX1 or NOX4 proteins.  
The limitations of the protein purification and identification procedures may be caused by 
the following reasons:  
Firstly, the MALDI-TOF MS technique turned out to have an insufficient sensitivity 
when compared to the immunodetection of NOX1 and NOX4 employing UV based 
visualization of protein bands on the PVDF membrane. This was, for example, 
demonstrated by experiment where the p22phox immunoreactive band was cut out from 
the PVDF membrane and MALDI-TOF MS analysis of the protein digest did not identify 
the p22phox protein (Figure 20F). Furthermore, the sample preparation and efficiency of 
protein extraction from the gel or PVDF membrane may also be critical in protein 
identification by MALDI-TOF MS. Another technical challenge of the purification 
procedure represented the optimization of HPLC. Since each step of HPLC purification 
decreased the amount of the analyzed protein significantly, high amounts of relative pure 
protein material (several tens of milligrams of proteins) had to be used for each run of 
chromatography. This limited numbers of repetition of purification experiments and use 
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of low capacity binding semi-preparative columns that are normally suitable for protein 
purifications. Particularly at RPC, amount of proteins loaded on column turned out to be 
problematic. Thus, an additional purification step such as cation exchange 
chromatography or ultrafiltration should be included before applying samples on RPC 
column.  
As an alternative purification procedure, 2D-GE was performed. However, also this 
approach appeared to be inappropriate. In particular, after 2D-GE separation, we did not 
detected proteins of interest at their expected or near to the expected molecular weight 
(Figure 20B, C, D, H). This might be explained, for example, by degradation or not 
proper solubility of the proteins of interest in the 2D-GE sample buffer or by insufficient 
transfer of protein to the PVDF membrane or by use of an improper pH-gradient. Another 
explanation could also be that, in general, membrane and hydrophobic proteins are often 
poorly represented in the second dimension of 2D gel. This phenomenon is not 
completely understood yet, but it may be based on protein-gel interactions during IEF 
[227].    
Up to now, only two groups have managed to purify endogenously expressed NOX 
family proteins. The DUOX2 protein was purified from pig thyroid membrane [228]. 
Solubilized membrane proteins were subjected to cation exchange chromatography, 
followed by an FAD-based affinity chromatography. Specific protein bands being 
immunoreactive with a DUOX antibody were cut from the gel, digested by trypsin and 
the peptides were separated on a RPC column and identify by MALDI-TOF MS. This 
purification procedure could be suitable for purification of NOX proteins generally since 
also other NOXs have a FAD binding domain.                
Also, the NOX2 protein in complex with p22phox (i.e. flavocytochrome b558) was 
purified from neutrophil membranes and identified by MALDI-TOF MS [229], [230]. 
The method was based on immuno-affinity chromatography purification of NOX2 by an 
anti-NOX2 monoclonal antibody coupled to A-sepharose. In contrast to our purification 
procedure of NOX1 or NOX4, this approach enables to recover a high amount (several 
tens of micrograms) of purified flavocytochrome b558 that allows detection by MS.  
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Despite of the fact that finally the NOX1 and NOX4 proteins could not be identified and 
other strategies of purification would have to be employed or developed for succeeding in 
this, several interesting observations were made:  
1. MOX1 H-15 detected strong bands at 60kDa and 45kDa in A549 cells. These bands or 
other bands near to the predicted size were previously described as NOX1 [18], [200], 
[20], [201], [216], [217], [218]. However, after performing the complete HPLC-based 
purification process, these bands were identified as pyruvate kinase and β-actin. 
Moreover, this antibody did not detect any band close to the predicted size in CaCo2 
cells. Thus, it is questioned whether the MOX1 H-15 antibody is suitable for the 
detection of endogenous NOX1. 
2. The 65kDa and 55kDa bands detected by NOX1wch (both in A549 and CaCo2 cells) 
were found in the flow through after AEC. AEC was used since most of the proteins have 
a pI in the neutral pH range (Molecular biology of the cell, Alberts et al., 2002) and thus, 
buffers with high pH (commonly used in AEC) would ensure their negative charge and 
good solubility. NOX1 is a basic protein with a pI of 8.8 (ExPASy proteomic server, 
Identification of isoelectric point, molecular weight and/or amino acid composition) and 
thus it would have a zero net charge in the chromatographic buffer used (Tris-HCl, pH = 
8.8). Since binding of the uncharged protein to the ion exchange chromatography column 
is unlikely, the recovery of NOX1 (detected with NOX1wch) in the flow through could 
be expected. However, MOX1 H-15 positive bands were eluated in certain fractions and 
not in the flow through. Similarly to the pI of NOX1, the theoretically predicted pI of 
NOX4, NOX2 and p22phox is higher than 8.8. Thus, the immunodetection of NOX4 
(67kDa), NOX2 (70kDa) and p22phox (22kDa) in the flow through after AEC was not 
very surprising (Figure 20C, E, F). On the other hand, posttranslation modifications such 
as glycosylation may decrease the pI of the protein. In accordance with this, the 80kDa 
band of NOX4 and the 90kDa band of NOX2 possibly representing glycosylated forms of 
these proteins were binding to the AEC column (Figure 20D, E). 
5.1.5 Contribution of NOX1 and NOX4 to ROS generation in A549 cells 
Initially, we showed that NOX1 mRNA was expressed in A549 at a significant higher 
level than NOX4 mRNA (Figure 8C).  
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Based on this observation, we were further interested in the relative contribution of 
NOX1- and NOX4-containing NADPH oxidases to ROS production in A549 cells. 
Measurement of H2O2 by Amplex Red reagent in the total cell lysate showed that knock-
down of NOX1 by siRNA significantly decreased the H2O2 concentration (about 20%), 
whereas knock-down of NOX4 did not display any significant ROS decrease. This 
observation may reflect that NOX1 is more strongly expressed than NOX4 in A549 cells. 
In this regard, of interest are studies demonstrating that NADPH oxidase 1 is primary 
producing O2.- whereas NADPH oxidase 4 is producing H2O2 [21], [231]. In our study, 
only H2O2 was measured since O2.- is suggested to be rapidly converted to H2O2. 
Additionally, also other groups have shown NOX1-dependent H2O2 generation [34], 
[232], [233]. Thus, measurement of H2O2 as product of both NOX1 and NOX4 appears to 
be relevant.  
 
5.2 Regulation and cross-talk of NOX1, Nrf2, Trx1 and HIF-1α under different 
oxygenation conditions 
Hypoxia and fluctuations of oxygenation resulting in intermittent hypoxia occur as 
consequences of different phathological states of organism. In particular, oxygen level 
fluctuations are typical characteristics of solid tumors [234], [235]. NADPH oxidase 1 is 
highly expressed in several adenocarcinoma cells (including A549 cells) and is of 
importance in cellular signaling possibly targeting the ROS- and oxygen- dependent 
transcription factors HIF-1 and Nrf2. Thus, we analysed the expression of NOX1, HIF-
1α, Nrf2 and the Nrf2 target Trx1 under different conditions of oxygenation. In 
particular, we investigated the regulation and a possible cross-talk between Nrf2 and 
HIF-1α with regard to NOX-dependent ROS signaling in continuous and intermittent 
hypoxia.  
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5.2.1 NOX1, NOX4, HIF-1α and Nrf2 expression, and NOX1-dependent ROS 
generation under different hypoxic conditions  
Initially, the expression of NOX1 mRNA and protein was analyzed in comparison to 
NOX4 under the different hypoxic conditions in A549 cells. The results showed that 
continuous long term hypoxia (H24) and intermittent hypoxia (IH6) induced NOX1 
mRNA and proteins to a similar degree (Figure 22A). An apparent increase of NOX1 
protein level was also visible after 12 hours of hypoxia. The induction of NOX1 
expression or activity under conditions of continuous hypoxia has also been described 
previously [236], [155], [237]. In contrast, NOX4 expression in A549 cells was not 
induced under the hypoxic conditions investigated (Figure 22B). In accordance with the 
induction of NOX1 expression under the different hypoxic conditions, also ROS derived 
from NOX1 displayed a most significantly increased level in IH6 and H24 (Figure 23B). 
Based on these studies, we conclude that intermittent hypoxia enhanced NOX1 
expression and NOX1-dependent ROS generation more rapidly than continuous hypoxia 
does.  
Furthermore, HIF-1α  levels were increased both in continuous long term and 
intermittent hypoxia whereas Nrf2 was increased only in intermittent hypoxia (Figure 
24A). Interestingly, Nrf2 knock-down revealed strong down-regulation of HIF-1α in 
intermittent hypoxia but not in continuous long term hypoxia (Figure 24B).  
 
5.2.2 Intermittent hypoxia and its relevance for physiological and 
pathophysiological conditions  
Cellular oxygenation in higher organisms is dynamic displaying alternations between 
stages of hypoxia and reoxygenation termed intermittent hypoxia. These conditions are 
observed under normal physiologic conditions (development, physical activity, exposure 
to hypoxic environment) and are also related to various pathophysiological conditions 
among them are pulmonary, cardial and vascular diseases, inflammation, transplantation 
and cancer.  
In particular, solid tumors are characterized by a hypoxic microenvironment that is 
caused by a high oxygen consumption rate due to the high metabolic rate of proliferating 
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cells, and due to structural deficiencies of tumor vessels that are not able to ensure stable 
oxygen supply [238], [239]. These hypoxic tumor areas are not stable since the oxygen 
concentrations in the tumor fluctuate in a temporal and spatial pattern, due to the 
dynamics of tumor progression and tumor angiogenesis, two processes that cause and 
counteract hypoxia [240]. Also, vasomotion of tumor arterioles, changes in the 
distribution and flux of red blood cells, and a progressive longitudinal decline in 
hemoglobin saturation play a role. These different phenomena result in conditions of 
intermittent hypoxia, where hypoxia and reoxygenation alternate with time, with periods 
ranging from minutes to days that are superimposed [241].  
In this context, we selected different sequences of hypoxic and normoxic intervals of 2 h 
(Figure 25A) principally mimicking intermittent hypoxia particular in vascularized 
tumors [242], [234], [235], [243], [244], [240]. Our protocol of intermittent hypoxia was 
also based on other cell culture studies where similar oxygenation conditions were used 
[245], [246], [247], [248] and on the presumption that HIF-1- and Nrf2-dependent gene 
regulatory pathways characterized by de novo mRNA and protein synthesis become 
effective in the range of hours. For example, induction of the Nrf2-dependent target gene 
peroxiredoxin 1, reflected by an increased protein level of this target, required about 2 h 
after switching from hypoxia to reoxygenation [202].  
Intermittent hypoxia is accompanied by elevated ROS generation, affecting signal 
transduction and gene regulation by both HIF-1α and Nrf2. In this regard, it is of note 
that Trx1 an Nrf2-dependent target gene has been demonstrated to induce HIF-1α [249], 
[161], [123], [196] thus Trx1 may represent a possible link between Nrf2 and HIF-1α. 
 
5.2.2.1 Regulation of HIF-1α, Nrf2, Trx1 and NOX1 expression, and NOX1-
dependent ROS generation in A549 cells treated by different alternating hypoxic 
and normoxic intervals  
Induction of HIF-1α was progressively enhanced after each cycle of 2 hours of hypoxia 
and 2 hours of reoxygenation in spite of the fact that during the reoxygenation period, the 
HIF-1α signal was almost not detectable (Figure 25B). This suggests that HIF-1α 
becomes more responsive to the induction after two hours of hypoxic exposure in the 
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later stages of intermittent hypoxia, resulting in a comparable HIF-1α protein level 
induction as observed after six hours of continuous hypoxic exposure. In contrast to IH6, 
where HIF-1α can accumulate only over a 2h of hypoxic stage (disappearing after each 
2h of reoxygenation step), in H6, HIF-1α can accumulate over a 6h of hypoxic stage.  
One study demonstrated that intermittent hypoxia (performed with three cycles of 
hypoxia (1 hour) interrupted by reoxygenation (0.5 hour) increased cell migration and 
cell survival of endothelial cells in a HIF-1α-dependent manner. Also, this study 
demonstrated that intermittent hypoxia enhanced the resistance of endothelial and tumor 
cells towards apoptosis caused by irradiation [245]. A further study showed that the 
phosphoinositide-3 kinase pathway and stimulation of mitochondrial respiration triggered 
the stabilization of HIF-1α  in endothelial cells in this pattern of intermittent hypoxia 
[246]. Another study identified protein kinase A as relevant for the progressive increase 
of phosphorylated HIF-1α observed in intermittent hypoxia in endothelial cells [247]. 
Furthermore, angiogenesis as indicated by cell migration and tubulogenesis of endothelial 
cells was enhanced in intermittent hypoxia in a HIF-1α dependent manner. This study 
also included analysis of Nrf2 that was observed not to be induced [248]. These 
observations suggest different mechanisms contributing to the enhancement of HIF-1α 
induction in intermittent hypoxia. In this context, our study employing patterns of 
intermittent hypoxia with stages of hypoxia and reoxygenation in the range of hours, 
demonstrated augmented HIF-1α signaling caused by Nrf2 in NOX1 expressing 
adenocarcinoma cells.  
HIF-1α was induced in both continuous and intermittent hypoxia, whereas Nrf2 was 
induced only in intermittent hypoxia but not in continuous hypoxic exposure (Figure 
25B). The Nrf2 target Trx1 that is known to induce HIF-1α was regulated accordingly 
(Figure 25B). This suggests that Nrf2 may enhance HIF-1α accumulation by Trx1 in the 
progressive hypoxic stages (2h) of intermittent hypoxia (IH6) to a similar extent as HIF-
1α accumulation occurring after 6h of continuous hypoxia (H6). The observation that 
HIF-1α is induced both in IH6 and H6 whereas Nrf2 and Trx1 are induced only in IH6 
suggests that different mechanisms are involved in HIF-1α induction. The contribution of 
different relevant mechanisms to HIF-1α induction may depend on the specific 
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conditions. These mechanisms include the control of HIF-1α degradation by PHD, HIF-
1α transactivation by FIH [250], degree of HIF-1α synthesis (e.g. translational control by 
mTOR) [160], posttranslational modifications of HIF-1α (e.g. phosphorylation [204], 
[251]) and regulation of the redox state of HIF-1α by Trx1 and Ref1 [161], [123]. Thus, 
we suggest that Trx1 plays a critical role in HIF-1α induction in intermittent hypoxia 
whereas other mechanisms dominate under conditions of continuous hypoxia. 
The total cellular ROS levels were elevated to a similar extent after IH6 and H6 (Figure 
26A). However, specific NOX1-derived ROS were most significantly increased after 
intermittent hypoxic exposure but not after continuous hypoxic exposure (Figure 26C). 
Overall, this observation reflects that other ROS sources beside NOX1 contribute to the 
total cellular ROS levels to a higher extent in continuous hypoxia  
(H6) than in intermittent hypoxia (IH6). Furthermore, it was striking that the NOX1-
derived ROS levels matched the regulatory pattern of Nrf2 and Trx1 being most strongly 
up-regulated in IH6 (Figure 25B). This NOX1-derived ROS increase was likely caused 
by increased NOX1 protein expression due to increased NOX1 mRNA levels (Figure 
25B, C). Accordingly, also A549 cells overexpressing NOX1 displayed significantly 
increased ROS level (Figure 27D).  
The mechanisms of endogenous NOX1 mRNA and protein up-regulation in intermittent 
hypoxia are unclear. Several transcription factors regulating NOX1 have been identified 
[57], [53], however the relevance of these factors for NOX1 expression in the conditions 
investigated in our study is not clear. In addition, increased ROS generation by a NOX1-
containing NADPH oxidase may be caused at the regulatory level of other participating 
NADPH oxidase subunits or by posttranslational modifications resulting in the activation 
of the NADPH oxidase complex. Such mechanisms have been described for NOX1 
[252], [253], [23].  
 
5.2.2.2 Regulation Nrf2 and Trx1 expression by NOX1  
Nrf2 induction at the protein level was dependent on NOX1 as shown by overexpression 
and inhibition of NOX1 (Figure 27A, B, D). Accordingly, the Nrf2 target gene Trx1 was 
regulated by NOX1 (Figure 28A, B, C) at the transcriptional level (Figure 22B) as 
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demonstrated by inhibition and overexpression of NOX1 (Figure 22D). Thus, in this 
study a link between NOX1 and Nrf2 dependent gene expression was explored as a new 
observation. 
Interestingly, the dependence of Nrf2 and Trx1 on NOX1 was most strongly pronounced 
in intermittent hypoxia, as demonstrated by inhibition of NOX1 (Figure 29) which 
indicated that an elevation of Nrf2 and Trx1 protein levels was caused by induction of 
endogenous NOX1 under these conditions. On the other hand, an induction of NOX1 is 
probably not the only mechanism regulating Nrf2 protein expression, since exposure of 
cells to continuous long term hypoxia (H24) led to an NOX1 up-regulation without 
concomitant Nrf2 induction (Figure 22A and 24A). This may suggest the presence of 
additional mechanism(s) activated during intermittent hypoxia that are involved in Nrf2 
stabilization or on the presence of additional mechanism(s) that are involved in Nrf2 
destabilization in continuous long term hypoxia. Nevertheless, NOX1 appears to be one 
of the essential factors stimulating Nrf2 activity during intermittent hypoxia. 
Accordingly, NOX1 inhibition by DPI (i.e. NADPH oxidase inhibitor) led to a decrease 
of Nrf2 protein level (Figure 27A, B) and NOX1 overexpression increased Nrf2 protein 
abundance (Figure 21D). These results strongly indicate a dependence of Nrf2 on NOX1-
derived ROS. The NOX1-dependent Nrf2 induction appeared to be mediated by the 
redox-dependent interaction of Keap1 with Nrf2, controlling its proteasomal degradation, 
since Nrf2 protein down-regulation after si-NOX1 treatment was prevented by a 
proteasome inhibitor (Figure 21C). Of note is that Keap1 is mutated in A549 cells. Thus, 
the interaction between Nrf2 and Keap1 and subsequent proteasomal degradation of Nrf2 
are diminished [185]. Howerver, it has been demonstrated that Nrf2 is induced by H2O2 
and that the Nrf2 target gene peroxiredoxin 6 is induced by siRNA ablation of Keap1 in 
A549 cells [254]. Thus Keap1 plays a significant role for the redox-dependent Nrf2 
turnover in A549 cells. 
 
5.2.2.3 Trx1 mediated regulation of HIF-1α by Nrf2 in NOX1-dependent manner   
In our experiments, Nrf2 ablation caused a decrease of Trx1 expression (Figure 28A). 
This is in accordance with other studies that described the ARE-dependent regulation of 
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Trx1 by Nrf2 [187], [186]. The inhibition of Nrf2 caused pronounced reduction in HIF-
1α levels in intermittent hypoxia. Also, the inhibition of Trx1 and NOX1 attenuated HIF-
1α, and these effects were pronounced in intermittent rather than continuous hypoxic 
exposure (Figure 30A, B). 
The sequence of signaling events leading to the enhancement of HIF-1α expression in 
intermittent hypoxic exposure is suggested from an experiment where overexpression of 
NOX1 and Trx1 was combined with the down-regulation of Trx1 and NOX1 expression 
by siRNA (Figure 31A, B). This experiment is based on the suggestion that NOX1 is the 
initial player (regulating Trx1 expression), and Trx1 the final player in exerting effects on 
HIF-1α in intermittent hypoxic exposure with Nrf2 as the crucial factor linking NOX1 
with Trx1. Accordingly, the inhibition of Trx1 in NOX1-overexpressing cells abolished 
the induction of HIF-1α, whereas inhibition of NOX1 in Trx1-overexpressing cells had 
no inhibitory effect on HIF-1α expression. It is also important to say that based on our 
results, other mechanisms of a cross-talk between NOX1 and Trx1 influencing HIF-1α 
activity cannot be excluded. For example, ROS generated by NOX1 may affect the 
redox-state and thus the function of Trx1.  
In this regard, also Trx1-dependent HIF-1α induction was demonstrated to be redox state 
dependent. This is likely based on the Trx1-mediated redox state regulation of cysteine 
residues within the transactivation domain of HIF-1α that consequently is critical for the 
binding of transcription factor coactivators, such as CBP/p300, to this domain [161]. 
Another study demonstrated that Trx1 overexpression led to an increased 
phosphorylation of translation activators 4E-BP1 and p70S6K, two well-known targets of 
mTOR [196]. This could result in an increase of HIF-1α synthesis. Our results showed 
that overexpression of Trx1 in both continuous and intermittent hypoxia induces HIF-1α 
to a similar extent (Figure 30C, D). This suggests that Trx1 is able to induce HIF-1α both 
in continuous and in intermittent hypoxia. However, HIF-1α induction by endogenous 
Trx1 is predominantly relevant in intermittent hypoxia since Trx1 is up-regulated only in 
this situation. This aspect is noteworthy regarding the occurrence of cancer drug 
resistance in hypoxic tumor areas, since several anticancer drugs are activators of Nrf2 
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[168], [181], [255], connecting this cytoprotective transcription factor by its target Trx1 
with HIF-1α. 
An interesting question is, whether NOX1 induces HIF-1α only through the Nrf2-Trx1 
pathway. In fact, this pathway seems to be relevant in our conditions of intermittent 
hypoxia that proceeded over several hours rather than minutes. The effects of ROS on 
HIF-1α are complex and are dependent on the source, type and kinetic of generation of 
ROS. In our work, we have observed a significant elevation of NOX1-dependent ROS 
levels after tens of hours of continuous hypoxia. Thus it is unlike that NOX1 derived 
ROS would be involved in signaling pathways leading to rapid HIF-1α activation. 
Nevertheless, additional mechanisms of HIF-1α induction by NOX1 both in intermittent 
and continuous hypoxia cannot be excluded.     
In sum, we identified a signal transduction pathway that causes the enhancement of HIF-
1α by Nrf2 in response to the studied pattern of intermittent hypoxia. In particular, this 
mechanism is relevant in adenocarcinoma cells expressing NOX1. ROS production by 
NOX1 was demonstrated to induce Nrf2 and Trx1 resulting in enhancement of HIF-1α 
induction. As a consequence, NOX1-expressing tumors may favor therapy resistance by 
increasing Nrf2 and HIF-1α in a tumor microenvironment exposed to conditions of 
intermittent hypoxia. Thus, therapeutic approaches for targeting of NOX1, Nrf2 and Trx1 
may be valid to eliminate therapy-resistant cancer cells.  
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6. Summary 
NADPH oxidase 1 and 4 are ROS generating enzyme complexes that play an important 
role in cellular signaling. The core subunits of NADPH oxidase 1 and 4 are NOX1 and 
NOX4, respectively.  
The immuno-detection of NOX1 and NOX4 proteins is a commonly faced problem. 
Protein bands of different molecular weights suggested to represent NOX1 and NOX4 
have been described in previous studies. These bands could represent, for example, 
different NOX splice variants, posttranslational modifications, proteolytic products or 
non-specifically immunoreacting proteins. Thus, well validated NOX1 and NOX4 
antibodies are critical for further functional and structural characterization of these 
proteins. Based on this, the aims of the first part of the work were: 1. To test and to select 
most suitable antibodies for the detection of NOX1 and NOX4 in human adenocarcinoma 
A549, CaCo2 cells and HUVEC, 2. To determine the subcellular localization of NOX1 
and NOX4, 3. To identify putative NOX1 and NOX4 proteins by mass spectroscopic 
(MS) analysis.    
Employing several commercially available and custom made NOX1 and NOX4 
antibodies it was obvious that neither of the antibodies detected any common band. 
Further, by employing specific siRNAs, custom made antibodies termed NOX1wch and 
NOX4jh were identified as suitable for NOX1 and NOX4 detection. Using these 
antibodies we also determined the presence of NOX1 and NOX4 in certain subcellular 
fractions. The results showed that both NOX1 and NOX4 were predominantly localized 
in the cytoskeleton fraction of A549 cells. This observation was partially in contrast to 
previous studies demonstrating the presence of endogenous NOX1 in the membrane 
fraction of different cell types including those that we used.   
In addition to proteins of the predicted size, the NOX1wch and NOX4jh antibodies also 
detected other protein species of lower or higher molecular weight. To identify these 
additional bands and to confirm the identity of NOX1 and NOX4 full length proteins,  
purification and MALDI-TOF MS analysis was performed. However, neither of the 
analysed proteins were identified as NOX-related which does not mean that this is not the 
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case. This might be explained, for example, by low abundance of NOX1 and NOX4 
proteins, or by technical limits of the protein purification and identification procedure.  
Furthermore, we determined that NOX1 predominates in ROS generation in comparison 
to NOX4 in A549 cells which was in accordance with a higher expression level of NOX1 
mRNA than NOX4 mRNA in A549 cells. 
In conclusion, this part of the work identified NOX1 and NOX4 antibodies that are 
suitable for the detection of NOX1 and NOX4 by Western blot. These antibodies were 
employed for the detection of NOX1 and NOX4 proteins in certain biochemical fractions 
representing different subcellular compartments. Furthermore, the open attempt for the 
purification and identification of NOX1 and NOX4 proteins was performed, and these 
results may be considered as the basis for further proteomic experiments.                                
 
NADPH oxidase 1 is a significant source of ROS in A549 cells. ROS are involved in the 
regulation of the transcription factors HIF-1 and Nrf2. Trx1 represents a target gene of 
Nrf2 that is known to induce HIF-1α. Intermittent hypoxia occurs in different 
pathophysiological conditions and is characterized by fluctuations of oxygen and ROS 
levels with impact on both HIF-1 and Nrf2.  
In this context, the aims of this part of the study were: 1. To analyse the expression of 
NOX1, HIF-1α , Nrf2 and Trx1 under different conditions of oxygenation in A549 cells, 
2. To analyse possible cross-talk(s) between these components, particularly under 
conditions of intermittent hypoxia.          
Initial experiments revealed, that whereas HIF-1α was up-regulated both in continuous 
and intermittent hypoxias, the Nrf2, Trx1 and NOX1 as well as NOX1-derived ROS were 
only up-regulated in intermittent hypoxia. NOX1 was determined as crucial for enhanced 
ROS production in intermittent hypoxia that in turn mediated induction of Nrf2 and Trx1. 
The regulation of Nrf2 and Trx1 by NOX1 was confirmed by both inhibition of 
endogenous NOX1 and overexpression of recombinant NOX1 protein. Employing a 
proteosomal inhibitor, NOX1 was demonstrated to activate Nrf2 at the level of protein 
stability. Subsequently, Nrf2-dependent Trx1 induction turned out to enhance HIF-1α 
signaling in intermittent hypoxia. 
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In sum, we identified a signal transduction pathway that causes the enhancement of HIF-
1α mediated by NOX1, Nrf2 and Trx1 in response to intermittent hypoxia. 
 
7. Zusammenfassung 
NADPH Oxidase 1 und 4 sind ROS generierende Enzymkomplexe mit einer wichtigen 
Funktion in der Signaltransduktion. Die wesentlichen Untereinheiten sind NOX1 und 
NOX4.  
Die Immunodetektion von NOX1 und NOX4 ist problematisch. Proteinbanden mit 
verschiedenem Molekulargewicht wurden beschrieben. Diese Banden könnten 
verschiedene Splicevarianten, posttranslationale Modifikationen, proteolytische 
Spaltprodukte oder unspezifische Proteine darstellen. Daher sind gut validierte NOX1 
und NOX4 Antikörper wesentlich für weitere funktionelle und strukturelle 
Untersuchungen von NOX1 und NOX4. Darauf basierend waren die Ziele des ersten 
Teils der Arbeit 1. Verschiedene Antikörper für NOX1 und NOX4 zu testen und 
möglichst geeignete Antikörper für den Nachweis von NOX1 und NOX4 in humanen 
Adenokarzinom- und HUVEC Zellen auszuwählen, 2. Die subzelluläre Lokalisation von 
NOX1 und NOX4 zu identifizieren, 3. Mögliche NOX1 und NOX4 Proteine durch 
Massenspektroskopie zu identifizieren  
Unter Einsatz verschiedener kommerziell erhältlicher und custom made NOX1 und 
NOX4 Antikörper war es offensichtlich, dass mit keiner der verwendeten Antikörper 
übereinstimmende Banden detektiert wurden. Basierend auf der spezifischen Inhibition 
von NOX1 und NOX4 mit siRNA wurde ein NOX1 Antikörper (NOX1wch) und ein 
NOX4 Antikörper (NOX4jh) als geeignet für den Nachweis von NOX1 und NOX4 
identifiziert. Mit diesen Antikörpern wurden NOX1 und NOX4 in verschiedenen 
subzellulären Fraktionen detektiert und analysiert. Dabei zeigte sich, dass sowohl NOX1 
als auch NOX4 vorwiegend in Fraktionen des Zytoskeletts enthalten war. Diese 
Beobachtung steht teilweise im Kontrast zu Studien, die das Vorhandensein von NOX1 
und NOX4 in den Membranfraktionen verschiedener Zelltypen (die von uns benutzten 
eingeschlossen) fanden. 
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Außerdem wurden mit den Antikörpern NOX1wch und NOX4jh andere Proteinspezies 
mit abweichenden Molekulargewichten detektiert. Diese Proteine und die mit erwartetem 
Molekulargewicht wurden nach verschiedenen Aufreinigungsschritten mit MALDI-TOF 
MS analysiert. Jedoch konnte keiner dieser Proteinbanden als NOX Protein identifiziert 
werden, was jedoch nicht heißt, dass es sich nicht um NOX Proteine handelt. Dies kann 
durch das geringe Vorkommen von NOX1 und NOX4 oder durch die Grenzen der 
verwendeten Proteinaufreinigung und Identifizierung bedingt sein.  
Außerdem wurde in der Studie aufgezeigt, dass NOX1 im Vergleich zu NOX4 die 
wesentliche ROS Quelle in A549 Zellen darstellt, was im Einklang mit den erhöhten 
mRNA Spiegeln von NOX1 im Vergleich zu NOX4 ist.  
Zusammenfassend wurden in diesem Teil der Arbeit Antikörper gegen NOX1 und NOX4 
identifiziert, die geeignet sind für den Nachweis von NOX1 und NOX4 im Western Blot. 
Diese Antikörper wurden dazu genutzt, um NOX1 und NOX4 Proteine in biochemischen 
Fraktionen, die verschiedene subzelluläre Kompartimente repräsentieren nachzuweisen. 
Außerdem wurde der noch offene Versuch der Aufreinigung und Identifizierung von 
NOX1 und NOX4 Proteinen durchgeführt, dessen Ergebnisse, die Grundlage für 
weitergehende Experimente in diese Richtung darstellen.  
 
NADPH Oxidase 1 ist eine signifikante Quelle von ROS in A549 Zellen. ROS sind an 
der Regulation der Transkriptionsfaktoren HIF-1 und Nrf2 beteiligt. Trx1 repräsentiert 
ein Zielgen von Nrf2, das bekanntermaßen HIF-1 induziert. Der zyklische Wechsel von 
Normoxie und Hypoxie (intermittent hypoxia) kommt unter verschiedenen 
pathophysiologischen Bedingungen vor und ist durch Fluktuationen der Sauerstoff und 
ROS Spiegel mit Einfluss auf HIF-1 und Nrf2 gekennzeichnet. In diesem Zusammenhang 
waren die Ziele dieses Teils der Arbeit: 1. Die Expression von NOX1, HIF-1α , Nrf2 and 
Trx1 unter verschiedenen Oxygenierungsbedingungen in A549 Zellen zu analysieren, 2. 
Eine mögliche Interaktion dieser Komponenten insbesondere in intermittent hypoxia zu 
untersuchen. Es zeigte sich, dass HIF-1α sowohl nach andauernder Hypoxie als auch 
nach intermittent hypoxia hoch reguliert war während Nrf2, Trx1, NOX1 und NOX1-
abgeleitete ROS nur nach intermittent hypoxia hoch reguliert waren. NOX1 erwies sich 
dabei als entscheidend für die erhöhte ROS Generierung in intermittent hypoxia, die 
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nachfolgend für die Induktion von Nrf2 und Trx1 relevant war. Die Regulation von Nrf2 
und NOX1 wurde bestätigt durch die Inhibition von endogenem NOX1 und die 
Überexpression von rekombinantem NOX1. Durch Verwendung eines Proteasom 
Inhibitors konnte gezeigt werden, dass NOX1 Nrf2 auf der Ebene der Proteinstabilität 
induziert. Nachfolgend, verstärkt die Nrf2-abhängige Induktion von Trx1 die HIF-
1α Antwort in intermittent hypoxia. 
Zusammenfassend wurde ein Signaltransduktionsweg aufgezeigt, der die HIF-1α 
Antwort in NOX1-, Nrf2- und Trx1-abhängiger Weise unter Bedingungen von 
intermittent hypoxia verstärkt.  
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